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Fluorescence imaging technique that provides the direct visualization of 
biological species or processes has become the most indispensable platform and 
modern imaging modality for fundamental studies of live science as well as in practical 
applications. However, the aggregation-caused quenching (ACQ) effect of 
conventional organic dyes has greatly hampered their biological applications and 
fluorescent nanoparticle fabrication. Recently, the novel fluorogens with unique 
aggregation-induced emission (AIE) characteristics which show intensified 
fluorescence in aggregate state have attracted great research interests in imaging and 
other biological applications. However, the applications of AIE fluorogens (AIEgens) 
have been mainly focused on the development small molecular bio-probes for sensing 
and detection, where the merits of AIE are not fully utilized. The AIE feature enables 
the fabrication of ultra-bright fluorescent nanoparticles, which can serve as the 
promising imaging reagents with high sensitivity and imaging contrast. In this thesis, I 
developed a general strategy to fabricate organic AIE dots with high brightness, good 
colloidal and photostability, surface functionalization, and desirable optical properties 
for in vitro and in vivo imaging, and image-guided photodynamic therapy.  
Firstly, a generic and simple strategy to synthesize ultra-bright AIE dots with 
amendable surface functional groups has been developed. Upon surface decoration with 
cell penetration peptide, the in vitro long-term cell tracking application was 
demonstrated. Following that, the Gadolinium (III) was successfully chelated onto the 
surface of AIE dots which possess bright fluorescence under two-photon excitation to 
detect the inflammation severity through the visualization of blood vascular leakage. 
AIEgen with efficient reactive oxygen species (ROS) generation in aggregate state was 
 viii 
 
further designed and encapsulated into AIE dots for image-guided targeted cancer 
photodynamic therapy. At last, efforts were made to address the intracellular 
localization of AIE dots, where AIE dots with cellular and mitochondria dual-targeted 
capabilities were fabricated, showing enhanced photodynamic therapy compared to 





LIST OF FIGURES 
Figure 1.1. Fluorescence photographs of A) DDPD with aggregation-caused quenching 
(ACQ) feature, and B) TPE and C) TPE-DDPD with aggregation-induced emission 
(AIE) characteristics in THF/water mixtures with different water fractions under UV 
illumination.39 Copyright 2013 American Chemical Society. ....................................... 5 
Figure 1.2. Schematic illustration of AIE mechanisms: restriction of intramolecular 
motions (RIM): RIR for TPE and RIV and THBA.46 Copyright 2014 Wiley-VCH. .... 7 
Figure 1.3. Schematic illustration of Silica AIE dots formations: A) ORMOSIL dots 
encapsulating BDSA.53 B) TPE-containing fluorescent silica AIE dots.56 Copyright 
2014 Royal Society of Chemistry and 2010 Wiley-VCH. ............................................. 9 
Figure 1.4. A) Chemical structures of TPE-CS, and the photograph of TPE-CS and 
FCS under light irradiation. B) SEM image of PTPEE dots. C) TEM image of Net-TPS-
DMA dots. D) AFM image of cRGD-TPE-Pt-DOX dots............................................ 13 
Figure 1.5.  A) Fluorescence image of HeLa cells stained by FSNPs at TPE 
concentration of 6 µM.56 B) Two-photon excited fluorescence image of MCF-7 stained 
by folate functionalized AIE dots.72 All the images share the same scale bar of 20 µm. 
Copyright 2010 Wiley-VCH and 2011 Royal Society of Chemistry. ......................... 20 
Figure 1.6. A) Chemical structures of 1a and 1b, b) SEM image of 1a aggregates 
formed in THF/water mixture. C) Fluorescence intensities and images of HeLa cell 
stained by 5 µM of 1b and 200 nM MTG at different passages (Psg).79 Copyright 2012 
Wiley-VCH. ................................................................................................................. 21 
Figure 1.7. A) In vivo non-invasive fluorescence imaging of H22-tumor-bearing mice 
after intravenous injection of TPETPADCM loaded BSA dots. B) Ex vivo fluorescence 
imaging on tumor tissue and major organs of mice treated with BSA dots.74 Copyright 
2012 Wiley-VCH. ........................................................................................................ 23 
Figure 1.8. A) Schematic illustration of AIE dots. B) Fluorescence time-traces of four 
individual AIE dots with different brightness levels. C) In vivo fluorescence imaging 
of the mouse subcutaneously injected with 1×106 of C6 glioma cells labelled with C) 
AIE dots, or D) QD655.76 Copyright 2013 Nature Publishing Group. ........................ 25 
Figure 1.9. 3D reconstructed two-photon fluorescence images of blood vessels in A) 
brain (0–425 µm), B) bone marrow (0–108 µm), and C) mouse ear skin (0–132 µm) 
from the mouse injected with BTPEBT AIE dots. All images share the same scale bar 
of 20 µm.82 Copyright 2013 Wiley-VCH. .................................................................... 26 
Figure 1.10. Confocal fluorescence images of the distribution of TPED (TPE-mPEG 
75 µM and DOX 5 µM) in MCF-7 cancer cells with different incubation time. All the 
 x 
 
images share the same scale bar of 20 µm.87 Copyright 2014 American Chemistry 
Society.......................................................................................................................... 28 
Figure 2.1. PL spectra of BTPEBT in THF/water mixtures with various water fractions, 
(A) fw = 0 to 50 vol%, (B) fw = 50 to 90 vol%. [BTPEBT] = 10 µM, λex = 422 nm. .. 45 
Figure 2.2. (A) LLS result of AIE-Tat dots in aqueous solution, inset is TEM image of 
AIE-Tat dots. (B) Hydrodynamic diameter changes of AIE-Tat dots upon continuous 
incubation in 1×PBS at 37 oC for 10 days. (C) Absorption and PL spectra of AIE-Tat 
dots in water at room temperature. (D) PL intensity changes of AIE-Tat dots at 547 nm 
in water at different pH. λex = 420 nm. ........................................................................ 46 
Figure 2.3. (A) Representative wide field fluorescence image of individual AIE-Tat 
dots. (B) Corresponding fluorescence intensity histogram of AIE-Tat dots (1338 dots) 
emitted during 100s. (C) Fluorescence changes of individual AIE-Tat dots after 100s 
laser scanning. .............................................................................................................. 48 
Figure 2.4. Representative fluorescence time traces of A) two AIE-Tat dots and B) two 
QD Tracker 585 within 100s........................................................................................ 49 
Figure 2.5. CLSM images of HEK 293T cells after incubation with AIE-Tat dots at 
different concentrations for 2 h. All the images share the same scale bar of 30 µm. .. 50 
Figure 2.6. A) Fluorescence, B) white field, and C) fluorescence/white field overlay 
images of HEK 293T cell after 2 h incubation with AIE dots (2 nM)......................... 51 
Figure 2.7. (A) CLSM images of HEK 293T cells after incubation with AIE-Tat dots 
(2 nM, 2 h) and Lysotracker Red DND-99 (75 nM, 30 min) in sequence. (B) 3D CLSM 
image of AIE-Tat dots treated HEK 293T cells. (C) Flow cytometry histograms of 
HEK293T cells stained by 2 nM AIE-Tat dots at 37 oC for 24 h (red line), unstained 
cells (black line) and a mixture of AIE-Tat dot-stained HEK293T cells and unstained 
cells (1:1; blue line) after 2 days co-culture. The histograms were recorded after co-
culturing for 2 days after mixing. ................................................................................ 52 
Figure 2.8. (A) Flow cytometry histograms of different cell lines after pMAX-GFP 
expression (red lines), AIE-Tat dots staining (blue lines) or without any treatment 
(black lines). ................................................................................................................. 53 
Figure 2.9. Fluorescence/transmission overlay images of pMAX-GFP expressed cells 
and AIE-Tat dots labelled cells. Insets are labelling rates measured by flow cytometry. 
All the images share the same scale bar. ...................................................................... 54 
Figure 2.10. A) Photostability of AIE-Tat dots and GFP in HEK293T cells. B) Cell 
viability of HEK293T cells after incubation with AIE-Tat dots at different 
concentrations for 24 and 48 h, respectively. .............................................................. 55 
 xi 
 
Figure 2.11. (A) Continuous monitoring of cell labelling rates by GFP or AIE-Tat dots 
for 10 days. (B) and (C) Flow cytometry histograms of HEK 293T cells after incubation 
with (B) 2 nM AIE-Tat dots or (C) 5 µg/well p-MAX-GFP plasmid overnight and then 
sub-cultured for designated times. (D) and (E) CLSM images of HEK293T cells 
labelled by (D) AIE-Tat dots or (E) pMAX-GFP at different days post-incubation. All 
the images share the same scale bar. ............................................................................ 56 
Figure 3.1. A) LLS result, and B) TEM image of AIE-Gd dots. C) Absorption and PL 
spectra of AIE-Gd dots before and after Gd chelation. D) Hydrodynamic size and 
fluorescence changes of AIE-Gd dots in 1× PBS buffer. ............................................ 69 
Figure 3.2. A) Luminescence image, B) luminescence intensity histogram, C) 
representative luminescence intensity time-traces of TPETPAFN loaded AIE dots. .. 70 
Figure 3.3. Two-photon absorption spectrum of AIE dots in water. .......................... 71 
Figure 3.4. Intravital TPFI of mouse ears A) without or B) with inflammation. The 
inflammatory ear was first treated with 1% croton oil (40 µL) for 3 h, followed by AIE-
Tat dots injection, and immediate imaging. ................................................................. 72 
Figure 3.5. Intravital TPFI of mouse ears A) without or B) with inflammation. The 
croton oil treatment and AIE dots injection were conducted as the same time. At 3 h 
post-injection, croton oil is removed, and the images were obtained. ......................... 74 
Figure 3.6. A) Amount of Gd and B) absorption of Evans blue in inflammation and 
healthy ears after designated croton oil treatment. The AIE-Gd dots and Evans blue was 
injected at the starting time of croton oil treatment. .................................................... 74 
Figure 3.7. A) Time-lapse images of AIE-Gd dots treated mouse ear before and after 
laser burn. B) Fluorescence intensity changes of selected two areas before and after 
laser burn. The neutrophils are GFP genetically modified. ......................................... 76 
Figure 4.1. A) Chemical structure of TPETPADCM. B) PL spectra of TPETPADCM 
(λex = 502 nm) in THF/water mixtures with different water fractions (fw). ................. 85 
Figure 4.2. A) PL spectra of the mixture of TPETPADCM aggregates and DCFH. B) 
DCFH PL peak intensity changes under continuous light irradiation. ........................ 86 
Figure 4.3. A) Size distribution and TEM image (inset), B) absorption and emission 
spectra, and C) ROS generation of TPETPADCM-cRGD dots. ................................. 88 
Figure 4.4. Confocal images of A) MDA-MB-231, B) MCF-7, C) NIH 3T3 cells, and 
D) free cRGD (50 µM) pre-treated MDA-MB-231 cells upon incubation with 
TPETPADCM-cRGD dots (1 μg/mL) for 1 h. The blue fluorescence from the nuclei of 
cells is dyed by Hoechst 33342, the red fluorescence is from TPETPADCM-cRGD dots. 
All the images share the same bar of 20 μm. ............................................................... 90 
 xii 
 
Figure 4.5. Detection of intracellular ROS production by dichlorofluorescein diacetate 
(DCF-DA) in A) MDA-MB-231, A) MCF-7 and C) NIH 3T3 cells after incubation with 
TPETPADCM-cRGD dots (10 μg/mL) followed by light irradiation. All the images 
share the same scale bar of 50 μm. .............................................................................. 91 
Figure 4.6. Inhibition of MDA-MB-231, MCF-7 and NIH 3T3 cells growth in the 
presence of different concentrations of TPETPADCM-cRGD dots A) without or B) 
with light irradiation (0.25 W cm-1, 2 min) followed by further incubation of the cells 
for 24 h. Data represent mean values ± standard deviation, n = 3. .............................. 92 
Figure 4.7. Cell apoptosis imaging using FITC-tagged Annexin V in MDA-MB-231 
(A), MCF-7 (B) and NIH 3T3 (C) cells incubated with TPETPADCM-cRGD dots after 
light irradiation. All images share the same scale bar of 20 μm. ................................. 93 
Figure 5.1. A) PL spectra of DPBA-TPE (10 µM) in THF/water mixtures with 
different water fractions. B) PL spectra of DPBA-TPE (10 µM) and DCFH (2 µM) 
mixture in water with different white light irradiation time (250 mW cm-2). ............ 104 
Figure 5.2. A) Absorption and PL spectra, and B) hydrodynamic diameters and surface 
zeta potentials of three AIE dots in water. TEM image of C) AIE-FA, D) AIE-TPP, 
and E) FA-AIE-TPP dots. ......................................................................................... 106 
Figure 5.3. ROS generation of FA-AIE-TPP dots in aqueous solution at A) varied dot 
concentrations with a fixed light power of 250 mWcm-2, and B) varied light powers 
with fixed dot concentration of 2 µg/mL upon irradiation for 300 s, using DCFH (2 µM ) 
as ROS indicator. ....................................................................................................... 108 
Figure 5.4. Flow cytometry histograms of A) NIH-3T3 cells and B) MCF-7 cells after 
incubation with AIE dots (20 µg/mL) for 4 h. ........................................................... 109 
Figure 5.5. CLSM images of A) MCF-7 cancer cells and B) NIH-3T3 normal cells after 
incubation with AIE dots (20 µg/mL) and MitoTracker Green (200 nM). AIE dots: Ex: 
543 nm, Em: > 650 nm; MitoTracker Green: Ex = 488, Em = 505 – 525 nm. The scale 
bar size is 10 µm for all images. ................................................................................ 110 
Figure 5.6. Viabilities of MCF-7 cancer cells and NIH-3T3 normal cells after 
incubation with A) AIE-TPP, B) AIE-FA, C) FA-AIE-TPP dots at varied 
concentrations, followed by white light irradiation (250 mWcm-2). D) and E) Annexin 
V labeled MCF-7 cells after incubation with FA-AIE-TPP dots (20 µg/mL) without 
(D) or with (E) light irradiations (250 mWcm-2). D) and E) share the same scale bar.
.................................................................................................................................... 111 
Figure 5.7. A-C) MMP changes of FA-AIE-TPP dots (20 µg/mL) treated MCF-7 
cancer cells measured by JC-1 (2 µg/mL) after light irradiation (100 mW cm-2) for A) 
0, B) 5, and C) 10 min. D) MMP changes of MCF-7 without FA-AIE-TPP dots 
treatment under light irradiation. All the images share the same scale bar. .............. 113 
 xiii 
 
Figure 5.8. A) White field image of FA-AIE-TPP dots treated NIH-3T3 and MCF-7 
cells before (up) and after 72 h culture (bottom). Both cells were incubated with FA-
AIE-TPP dots (20 μg/mL based on DPBA-TPE mass concentration) for 4 h, followed 
by light exposure (100 mW/cm2) for 10 min. B) The effects of AIE dots treatment on 





LIST OF SCHEMES 
Scheme 1.1. Schematic illustration of organic AIE dots from A) self-assembly, and B) 
polymerization.61 Copyright 2014 Royal Society of Chemistry. ................................. 12 
Scheme 1.2. A) Chemical structure of TPETPAFN and its emission intensity changes 
in THF/water mixture. B) Schematic illustration of the fabrication of PLGA-PEG-Fol 
AIE dots eccentrically or homogeneously loaded with TPETPAFN.73 Copyright 2012 
Wiley-VCH. ................................................................................................................. 17 
Scheme 1.3. Chemical structure of Net-TPE-PEI-DMA and the schematic illustration 
of it as pH-responsive light-up AIE dots for targeted imaging and selective suppression 
of cancer cells.68 Copyright 2015 Royal Society of Chemistry. .................................. 30 
Scheme 2.1. A) Chemical structures of BTPEBT, DSPE-PEG2000, and DSPE-PEG2000-
Mal. B) Schematic illustration of AIE-Tat dots formation. ......................................... 44 
Scheme 3.1. Chemical structures of DSPE-PEG2000-NH2, TPETPAFN and DOTA, and 
the schematic illustration of AIE-Gd dots formation. .................................................. 67 
Scheme 4.1. Schematic illustration of TPETPADCM-cRGD dots for image-guided 
photodynamic therapy. ................................................................................................. 87 
Scheme 5.1. Chemical structure of DPBA-TPE. ...................................................... 103 
Scheme 5.2. Schematic illustration of FA-AIE-TPP dots for specific targeting of FR-






LIST OF SYMBOLS 
AA   Arylic acid 
ACQ   Aggregation-caused quenching 
ADSCs  Adipose-derived stem cells 
AFM   Atomic force microscopy 
AIE   Aggregation-induced emission 
APS   (3-Aminopropyl)triethoxysilane  
BDSA   9,10-Bis[4-(4-aminostyryl)styryl]anthracene derivative 
BMSCs  Bone marrow stem cells 
BODIPY  Boron-dipyrromethene 
BSA   Bovine serum albumin 
CLSM   Confocal laser scanning microscopy 
cRGD   Cyclic arginine−glycine−aspartic acid tripeptide 
CS   Chitosan 
CTAB   Cetyltrimethyl ammonium bromide 
DCF-DA  Dichlorofluorescein diacetate 
DCFH   Dichlorofluorescin 
DCM   Dichloromethane 
DDPD N,N-dicyclohexyl-1,7-dibromo-3,4,9,10-
perylenetetracarboxylic diimide 
DL   Degree of labelling 
DMA   Dimethylmaleic anhydride 
DMEM  Dulbecco's Modified Eagle Medium 
DMF   Dimethylformamide 
DMSO   Dimethyl sulfoxide 
DOX   Doxorubicin 
 xvi 
 
DPBF   1,3-Diphenylisobenzofuran 
DSPE-PEG2000 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-2000] 
EPR   Enhanced pemearbility and retention 
FA   Folic acid 
FBS   Fetal bovine serum 
FITC   Fluorescein isothiocyanate 
FP   Fluorescent protein 
FRET   Förster resonance energy transfer 
Gd   Gadolinium 
GFP   Green fluorescent protein 
HPS   Hexaphenylsilole 
IC50   Half maximal inhibitory concentration  
ICP-MS  Ionic coupled plasma mass spectrometry 
LLS   Laser light scattering 
MRI   Magnetic resonance imaging 
NIR   Near infrared 
NMP   N-Methyl-2-pyrrolidinone  
NMR   Nuclear magnetic resonance 
NPs   Nanoparticles 
NPAFN  Bis(4-(N-(1-naphthyl) phenylamino)-
phenyl)fumaronitrile 
PBS   Phosphate buffer saline 
PDT   Photodynamic therapy 
PEG   Polyethylene glycol 
PEG-b-PCL  Poly(ethylene glycol)-b-poly(e-caprolactone) 
PEG-b-PS  Poly(ethyleneglycol)-b-poly(styrene)  
PEI   Polyethyleneimie 
 xvii 
 
PL   Photoluminescence 
PLGA   Poly(lactide-co-glycolide) 
PMAA-b-PS  Poly(methacrylic acid)-b-poly(styrene)  
PSs   Photosensitizers 
Pt   Cisplatin 
PTPEE  Ppoly[(2-(4-vinylphenyl)ethene-1,1,2-triyl)tribenzene] 
PVA   Poly(vinyl alcohol) 
QDs   Quantum dots 
RAFT   Reversible addition–fragmentation chain transfer  
RES   Reticuloendothelial system 
RIM   Restriction of motions 
RIR   Restriction of rotation 
RIV   Restriction of vibration 
ROS   Reactive oxygen species 
SEM   Scanning electron microscopy 
St   Styrene 
TEM   Ttransmission electron microscopy 
TEOS   Tetraethsilane 
THBA   Tetrahydro-bidibenzo-annulenylidene  
THF   Tetrahydrofuran 
TICT   Twisted intramolecular charge transfer 
TPA   Two-photon absorption 
TPE   Tetraphenylethene 
TPEE   (2-(4-Vinylphenyl)ethene-1,1,2-triyl)tribenzene 
TPE-ICT 1-[4-(Isothiocyanatomethyl)phenyl]-1,2,2-
triphenylethene  
TPFI   Two-photon fluorescence imaging 
 xviii 
 
TPP   Triphenylphosphine 
TPS   Tetraphenylsilole 
VTES   Triethoxyvinylsilane 














Biological imaging that provides direct visualized information of biological species 
or processes has become the most important modern tool for fundamental studies of 
live science and in the practical and clinical applications such as diagnosis, prognosis 
and therapy of cancer and other diseases.1-6 Up to now, a large variety of imaging 
modalities have been developed and widely applied in the biological investigation from 
the macroscopic to microscopic, and further to sub-cellular levels. Among these 
advanced imaging techniques, such as computer tomography,7, 8 magnetic resonance 
imaging (MRI),9-11 ultrasound,12 and photoacoustic imaging,13, 14 fluorescence imaging 
technique has served as a reliable and vital indispensable platform for non-invasive bio-
detection, bio-sensing and bio-imaging in the sub-cellular, cellular, tissue, and whole 
body levels due to their advantages in the regards of inexpensive materials, 
manoeuvrable equipment and high temporal-spatial resolution.15-17  To achieve optimal 
physiological behaviour and reliable performance with high resolution contrast, high 
sensitivity, and minimal perturbation to biological interference, these fluorescent 
materials should possess high brightness, good photostability, and ease of 
functionalization. 
The engineered expression of fluorescent proteins (FPs) inside cells has dominated 
the field of fundamental cell study, such as programmed cell death, cell linage 
commitment, and other biochemical processes.18-21 However, the integration of FP 
genes into cells genomes is facing the safety issues of introduction of random 
insertional gene mutation,22, 23 while non-viral approach exhibited unstable and cell-
dependent FP transfections.24, 25 Moreover, the existence of time lag between FP 
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expression and transcriptional, translational and post-translationally regulated 
processes will result in inconsistence when immediate signal readout is required.26-28 
Conventional organic fluorescent dyes have been extensively used in various 
imaging related biological applications. Numerous organic fluorogens (e.g., rhodamine, 
fluorescein, and BODIPY) and their later modified derivatives have been developed 
and showed their own merits in cell imaging, cellular organelle detection, and cell 
dynamics studies. However, these traditional organic dyes suffer from intrinsic 
drawbacks which greatly hampered their biological applications. One of the particular 
drawbacks is their poor photo-resistance to irradiation which results in rapid diminished 
fluorescence under continuous excitation, making them not suitable for bio-imaging 
analysis over long period. On the other hand, their optical properties are largely 
susceptible to surrounding inferences and the unexpected interactions with random 
biomolecules and proteins in complex environment would most-likely mislead the 
experiment results when high sensitivity and resolution are required.  
Encapsulation of the organic dyes into nanoparticles (NPs) or dots has been 
served as a promising strategy to increase their stability in both in vitro and in vivo 
applications. Various matrices have been developed for the dye encapsulation, such as 
lipids, polymers, and silica. These matrices prevent the unexpected interactions of the 
dye molecules with surrounding molecules or oxygen which improves the 
photostability and the resistance to surrounding stimuli changes.  Moreover, the surface 
of these fluorescent NPs can be further functionalized with different ligands, functional 
molecules, adapters, peptides or antibodies for targeting and other specific purposes. 
However, the intrinsic narrow Stokes shifts still remain challenged for multiplex 
imaging applications. On the other hand, the fluorescence of conventional organic dyes 
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will be quenched at high concentration or in aggregated states, which is known as 
aggregation-caused quenching (ACQ).29 The notorious ACQ phenomena not only 
forces the use of dilute solution of bio-probes, leading to poor sensitivity and reliability, 
but also results in weakened brightness when being encapsulated into NPs. For example, 
encapsulating Nile Red into NPs will result in almost zero fluorescence at high loading 
percentage,30 largely compromising imaging contrast. 
In the respect of brightness, photostability, and Stokes’ Shifts, the fluorescent 
spherical semiconductor crystals known quantum dots (QDs) have shown their own 
merits in the field of optoelectronic devices and biomolecules detection and fluorescent 
imaging.31, 32 The broad absorption and narrow emission spectra also make QDs 
especially suitable for multi-colour fluorescence imaging with single excitation 
wavelength to simultaneously monitoring different cellular activities. However, QDs 
exhibit fluorescence intermittency under excitation, known as ‘blinking’, which makes 
them not suitable for single particle tracing studies.33 In addition, the inevitable fact that 
QDs are made up of heavy metal elements that are intrinsic toxic to cells, animals and 
human beings has greatly limited their practical applications and clinical studies.34 
ACQ phenomena also has been found on QDs.35 As a consequence, novel fluorescent 
materials with high brightness, good photostability and less cytotoxicity are highly 
desirable for imaging-related biological applications. 
1.2 AIE Fluorogens 
As described in previous section, the ubiquitous ACQ effect has been 
compromising the detection sensitivity and imaging resolution contrast. Researchers 
have been forced to utilize diluted fluorogens in their studies, where the emission is 
often weak and the small amounts of dyes are easily and quickly photo-bleached under 
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harsh laser, which have led to poor sensitivities and caused many inconvenience and 
problems.36-38 Since most fluorogens are hydrophobic, they tend to form cluster in the 
hydrophobic cavities or attach onto bio-molecule surface with diminished emission. In 
addition, despite of the rapid progresses of nanotechnology and nanoparticle systems, 
the notorious ACQ effect has greatly hampered the development of conventional 
organic dye based NPs for biological applications. 
 
Figure 1.1. Fluorescence photographs of A) DDPD with aggregation-caused quenching 
(ACQ) feature, and B) TPE and C) TPE-DDPD with aggregation-induced emission (AIE) 
characteristics in THF/water mixtures with different water fractions under UV illumination.39 
Copyright 2013 American Chemical Society. 
This inevitable ACQ phenomenon in biological detection and imaging has 
become a harmful photophysical effect and thorny obstacle in luminescence researches 
and practical applications. Taken N,N-dicyclohexyl-1,7-dibromo-3,4,9,10-
perylenetetracarboxylic diimide (DDPD) as an example (Figure 1A), the structures of 
these conventional organic dyes are normally composed of planar aromatic rings.39 In 
good solvent such as tetrahydyrofuran (THF), DDPD emits strong fluorescence under 
UV illumination. In poor solvent such as THF/water mixture with increased water 
fraction (70%), these disc-like DDPD molecules tend to form strong π-π stacking 
structures, which promote the excimer and exciplexes formation, resulting in obvious 
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ACQ phenomenon.39 Many efforts and different chemical and physical approaches 
have been taken to mitigate the ACQ effects, but with limited success.40-42  
In 2001, Tang and co-authors discovered and reported a new system of 
fluorogens, which is found to be non-fluorescence when molecularly dispersed in good 
solvent but become highly emissive in poor solvent or form aggregates.43, 44 This novel 
and exciting phenomenon that is exactly opposite to ACQ effect is known as 
aggregation-induced emission (AIE). One of the typical AIE fluorogens (AIEgens) is 
tetraphenylethene (TPE) (Figure 1.1B), which is non-emissive when molecularly 
dispersed in THF solution but can be induced to emit strong blue emission when 
forming aggregates in THF/water mixture with high water fraction.42 Along with the 
development of material science, more fluorogens with AIE characteristics have been 
discovered such as tetraphenylsilole (TPS), hexaphenylsilole (HPS) and other 
derivatives. Moreover, recent discovery that amalgamation of AIEgens with 
conventional ACQ fluorogens will efficiently transform ACQ fluorogens to AIEgens 
further enriched the class of AIEgens with more emission colours and applications. For 
example, conjugation TPE moieties to DDPD skeleton will achieve a new fluorogen 
TPE-DDPD, which is not emissive in THF but shows bright red emission in aggregate 
(Figure 1.1C).45 This discovery of AIEgens can take the advantage of nature aggregate 
formation in biological system rather than tackling or fighting against it, which have 




Figure 1.2. Schematic illustration of AIE mechanisms: restriction of intramolecular motions 
(RIM): RIR for TPE and RIV and THBA.46 Copyright 2014 Wiley-VCH. 
Along with its discovery, many efforts have been put into the study of AIE 
mechanism. Up to now, it has come to a clear picture of the AIE mechanism, which is 
the restriction of intramolecular motions (RIM).46-48 The RIM includes two parts: 
restriction of intramolecular rotation (RIR) and restriction of intramolecular vibration 
(RIV). Taken TPE as an example, which exhibits non-planar propeller like structures. 
These four phenyl rings can undergo free rotation or twist when molecularly dispersed, 
which will transfer the photonic energy into heat or active intramolecular rotation 
through the non-radiative decay (Figure 1.2). Unlike conventional fluorogens, the π-π 
stacking of AIEgens in aggregated state is blocked, which also blocks the free rotation 
of molecular rotator and the non-radiative decay. As a consequence, the radiative 
pathways become dominated, which leads to intensified fluorescence. Similarly, 
aggregation can also block the free intramolecular vibration for some AIEgens 
(tetrahydro-bidibenzo-annulenylidene (THBA)) and modulate the relaxation non-
radiative decay pathway to radiative pathways (Figure 1.2).49, 50 The discovery and 
development of AIE fluorogens have provided great opportunities and showed unique 
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potentials in molecular sensing, protein detection, cellular imaging, bacteria imaging, 
and tissue imaging. Most recently, some AIEgens also have been found to be able to 
efficiently generate reactive oxygen species (ROS).51,52 In addition, opposite to 
traditional photosensitizers (PSs), AIEgens showed efficient ROS generation in 
aggregate state, making them promising in photodynamic therapy (PDT) over 
conventional photosensitizers (PSs), which further expanded their biological 
applications.  
This intensified fluorescence once in aggregated state inspired the design of 
various light-up probes based on binding or cleavage induced emission for detection of 
wide ranges of molecules, proteins or biological processes. Mostly important, it also 
means that the AIE feature of the novel class of fluorogens can be fully utilized by using 
their highly emissive aggregates to form NPs with ultrahigh brightness as efficient 
imaging contrasts for bio-imaging applications with much better imaging resolution 
and biocompatibility.  
1.3 Synthesis of AIE Dots 
Since its discovery by Tang et al, the research fields of AIEgens have been 
rapidly developed and attracted large number of researchers due to the unique and 
amazing merits of AIEgens. Up to now, various approaches and strategies have been 
reported for fabrication of AIE dots for different biological applications.39, 53 In general, 
the synthesis of AIE dots involves the transferring molecularly dissolved AIE 
molecules from organic solvent to aggregates in water phase with stabilized 
morphology and size. Based on the material difference to synthesize AIE dots, the 
methods have been classified into two groups: silica AIE dots and organic AIE dots.  
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1.3.1 Silica AIE Dots  
 
Figure 1.3. Schematic illustration of Silica AIE dots formations: A) ORMOSIL dots 
encapsulating BDSA.53 B) TPE-containing fluorescent silica AIE dots.56 Copyright 2014 Royal 
Society of Chemistry and 2010 Wiley-VCH. 
The pioneer work of silica AIE dots is reported by Prasad et al.54 In 2007, 
Prasad’s group reported the encapsulation of a new AIEgen, 9,10-bis[4-(4-
aminostyryl)styryl]anthracene derivative (BDSA) with organically modified silica 
(ORMOSIL) NPs for two-photon fluorescence imaging. This BDSA fluorogen showed 
dimed two-photon fluorescence when molecularly dissolved but was induced to bright 
two-photon emission in aggregate. To form the silica AIE dots, N-Methyl-2-
pyrrolidinone (NMP) solution containing BDSA and triethoxyvinylsilane (VTES) was 
injected into aqueous micelle solution prepared by Aerosol OT (AOT) (Figure 1.3A). 





nonpolar interior of AOT micelles in VTES sol by transient emulsification and 
spontaneous co-precipitation via solvent displacement process. The ORMOSIL AIE 
NPs showed excellent encapsulation performance of AIE aggregates, which showed 
intense fluorescence under two-photon excitation. With the presence of silanol moiety 
( ≡ Si-OH and ≡ Si-O-1) at surface, the silica AIE NPs are ease of surface 
functionalization with various targeting ligands, which was successfully demonstrated 
in in vitro two-photon imaging with low cytotoxicity. The same group also co-
encapsulated the same AIEgen with a PS for photodynamic therapy.55 The 
photosensitizer is indirectly excited by the energy transferred from the BDSA due to 
their close proximity, and this ORMOSIL AIE dots exhibited efficient in vitro 
anticancer effects by the generation of ROS under two-photon excitation.  
In 2010, Tang et al. reported a new method for the fabrication of highly emissive 
silica AIE dots with core-shell structures by modified Stöber methods.56 In this method, 
TPE was covalently conjugated with (3-aminopropyl)triethoxysilane (APS).  The TPE-
silica nano-cores are obtained after the sol-gel reaction in the presence of ammonium 
hydroxide in aqueous solution, which is further subjected to sol-gel reaction with 
tetraethylorthosilicate to yield FSNP-1 AIE dots with fluorescent TPE aggregates as 
the core and silica as the shell (Figure 1.3B). The resultant FSNP-1 dots are uniformly 
dispersed with tuneable sizes from 50 to 300 nm by controlling reaction conditions. The 
silica-AIE dots exhibit high emission, excellent colloidal stability, and low cytotoxicity, 
which can serve as excellent imaging regents for visualization of the cytoplasm of HeLa 
cells. Tang’s group further introduced –NH2 groups to FSNP-1 dot surfaces by using 
(3-aminopropyl)triethoxysilane, the resultant FSNP-1-NH2 dots were further decorated 
with biotin for specific cancer cell detection and imaging.57 A modified two-step Stöber 
method together with reverse micro-emulsion was also developed to covalently 
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immobilize of AIEgens on silica NPs.58  Silica AIE dots with bright fluorescence and 
strong magnetization were further fabricated via surfactant-free sol–gel reaction of 
tetraethoxysilane and silole-functionalized siloxane in the presence of citrate-coated 
magnetic NPs.59 In 2014, Wei’s group reported a non-covalently encapsulation of 
AIEgens into silica dots.53, 60 Instead of chemically melding AIEgens with silica 
precursors, octadecyltrimethoxysilane with long alkyne chain was used as the silicate 
precursor and structure-driving template to encapsulate AIEgens to fabricate the mono-
dispersed silica AIE dots with excellent water dispersiblity, low cytotoxicity and 
excellent cellular internalization capability.    
1.3.2 Organic AIE Dots 
Organic AIE dots were mainly fabricated by polymers or oligomers 
encapsulation approaches. These amphiphilic polymers or oligomers tend to self-
assemble into stable nano-aggregates in aqueous solution. When AIEgens were 
covalently linked or non-covalently mixed with these polymers, AIEgens doped NPs 
with bright fluorescence will be observed. Several methods have been developed to 
prepare these AIE dots, including self-assembly, polymerization, emulsion, and nano-
precipitation. Through controlling amphiphilicity, matrix molecular weight, matrix to 
AIEgens ratio, and initial concentration, et al., AIE dots with different sizes and 
properties can be fabricated to fulfil different biological applications. 
1.3.2.1 Self-assembly 
A typical procedure for self-assembly approach is shown in Scheme 1.1A. 
These AIE-containing polymers were firstly dissolved in a good organic solvent, which 
is miscible with the ‘poor’ solvent such as water. When they are transferred from the 
organic solvent to an excess amount of water, they tend to self-assemble to nano-
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aggregates. The hydrophobic segments tend to collapse with each other to form the core, 
while hydrophilic segments will present as the shell to stabilize the core to form the 
organic dots.61 The AIEgens can locate at the centre, terminal, or side-chains of these 
amphiphilic polymers or oligomers.  
 
Scheme 1.1. Schematic illustration of organic AIE dots from A) self-assembly, and B) 
polymerization.61 Copyright 2014 Royal Society of Chemistry. 
The early works of AIE dots prepared from self-assembly were reported by 
Tang et al.62, 63 In this demonstration, they synthesized a TPE derivate, 1-[4-
(isothiocyanatomethyl)phenyl]-1,2,2-triphenylethene (TPE-ITC), which is also AIE-
active, where its fluorescence intensity in THF/water mixture (water fraction of 90%) 
is ~36200-fold stronger than that in THF solution. TPE-ITC is then linked to the side 
chains of Chitosan (CS) to yield TPE-CS (Figure 1.4A). They also labeled CS side 
chains with fluorescein, a typical ACQ unit, to yield FCS for comparison. The solid 
powders of TPE-CS showed bright greenish-blue light, which is increased with the 
degree of labelling (DL) of TPE, while FCS at low DL showed yellow light, but the 







1.4A). The TPE-CS dots were synthesized by ionic gelation method, where sodium 
tripolyphosphate solution was dropwisely added into TPE-CS acetic acid aqueous 
solution under constant stirring. The TPE-CS dots were formed via the crosslinking of 
the amino groups on chitosan and the phosphate group on tripolyphosphate. The 
obtained AIE dots are spherical in shape and well dispersed in water with size of 170 
nm. The suspension of TPE-CS dots emit strong blue fluorescence under laser 
illumination due to the AIE feature of TPE moiety. The TPE-CS dots were ready for 
cellular internalization and showed excellent cellular retention without contaminating 
co-cultured other cell lines.  
 
Figure 1.4. A) Chemical structures of TPE-CS, and the photograph of TPE-CS and FCS 
under light irradiation. B) SEM image of PTPEE dots. C) TEM image of Net-TPS-DMA dots. 
D) AFM image of cRGD-TPE-Pt-DOX dots. 
In 2014, Xu and co-authors reported a new self-assembly approach to prepare 
AIE dots.64  In this approach, AIE-based polymers were firstly prepared by the 







vinylphenyl)ethene-1,1,2-triyl)tribenzene (TPEE). The resultant poly[(2-(4-
vinylphenyl)ethene-1,1,2-triyl)tribenzene] (PTPEE) showed typical AIE characteristics. 
To prepare the PTPEE dots, the polymer is transferred from THF to water under 
sonication to induce the self-assembly process to form AIE dots. Scanning electron 
microscope (SEM) was used to study the morphology of PTPEE dots, as shown in 
Figure 1.4B, these dots are spherical particles with one dimple observed on each particle. 
In addition, dot sizes can be controlled by the speed and sequence of THF addition. 
These AIE dots are very stable, no precipitation is observed after storage in solution for 
one week. Wei el al also reported the fabrication of AIE dots based on the similar 
concept of polymerization followed by self-assembly.65, 66 Through controlling the 
degree of polymerization, the AIE dots size can be fine-tuned from 100 to 500 nm.67  
Besides attaching AIEgens to polymers, modifying AIEgens with small 
hydrophilic ligands can also lead to self-assemble to form AIE dots.68, 69 In 2014, Liu 
et al attached polyethyleneimine (PEI) to TPS, which was further modified with 2,3-
dimethylmaleic anhydride (DMA) to afford Net-TPS-PEI-DMA. The Net-TPS-PEI-
DMA showed particle size around 170 nm and spherical shapes as observed by 
transmission electron microscope (TEM) image (Figure 1.4C). The same group also 
attached two anticancer drugs, doxorubicin (DOX) and cisplatin (Pt) and targeting 
moiety cRGD to TPE, and the resultant cRGD-TPE-Pt-DOX can self-assembly into 
AIE dots with size around 120 nm as observed by atomic force microscopy (AFM) 
image (Figure 1.4D). 
1.3.2.2 Polymerization 
Utilizing the polymerization method to fabricate AIE dots, it requires the 
monomers and AIEgens are well dispersed into stable oil droplets in the aqueous 
solution, and hence the polymerization and self-assembly processes will happen 
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simultaneously (Scheme 1.1B) to afford the AIE dots after organic solvent evaporation. 
In 2014, Wei and co-workers reported the emulsion polymerization method for AIE 
dots fabrications.70 In this method, they synthesize the polymerizable AIE dyes (PhE) 
with double bond as the end functional groups. PhE and two other monomers acrylic 
acid (AA) and styrene (St) were well dispersed as small oil droplets in organic 
solvent/water mixture in the presence of emulsifier sodium dodecyl benzene sulfonate 
(SDBS). The addition of APS as the initiator starts the polymerization to yield PhE-Pst 
dots. During the emulsion polymerization, hydrophobic PhE and St segments 
aggregated as the core while the hydrophilic AA segments served as the protective shell. 
PhE-Pst dots exhibited uniform spherical shape with size around 400 nm and zeta 
potential of -45 mV. The PhE-Pst dots exhibited strong orange emission under UV lamp 
illumination, which were able to label HeLa cells with excellent biocompatibility.  
1.3.2.3 Polymer Encapsulation 
  Silica AIE dots are suffering from the non-biodegradable nature, while self-
assembly and polymerization approaches required tedious chemical synthetic work. In 
this regard, encapsulation of AIEgens by polymeric matrices seems to be a promising 
approach for fabrication of AIE dots, which not only helps to minimize the inference 
from surrounding environment, but also exhibits excellent biocompatibility. Up to now, 
various polymeric matrices, including block-copolymers, lipids, and proteins have been 
reported for AIE dots fabrication.   
The early work of polymer encapsulated AIE dots was reported by Jen et al.71 
In their demonstration, three block copolymers, poly(ethylene glycol)-bpoly(e-
caprolactone) (PEG-b-PCL), poly(ethyleneglycol)-b-poly(styrene) (PEG-b-PS), and 
poly(methacrylic acid)-b-poly(styrene) (PMAA-b-PS) were used as the encapsulation 
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matrices, while HPS was selected as the fluorescent AIE core. Upon transferring them 
from organic solvent to water, the block copolymers will form micelles, where the core 
will act at the reservoir for AIEgen aggregates, and the hydrophilic parts will act as the 
brush-like protective corona to stabilize the AIE micelles. The larger hydrophobic 
segments of the polymeric matrix and the higher loading ratio of AIEgens will lead to 
increased AIE micelle sizes. In addition, the quantum yield of HPS loaded PMAA-b-
PS micelles can reach to 62% at HPS loading ratio of 30%, which is much higher than 
that of HPS aggregates in poor solvent (22%), due to that the micelle encapsulation not 
only confines the spatial movement of HPS aggregates, but also prevents the direct 
contact of AIEgens with water media.  In addition, they also demonstrated that the co-
encapsulation of HPS and bis(4-(N-(1-naphthyl) phenylamino)-phenyl)fumaronitrile 
(NPAFN) will result in efficient Föster resonance energy transfer (FRET) from HPS to 
NPAFN, leading to largely increased red fluorescence without affecting the size and 
surface morphology of the micelles. However, the instability of micelle in aqueous 
solution still remain a big challenge for long term storage and use of AIE micelles. 
In 2011, Liu et al. reported a modified nano-precipitation method for the 
fabrication compact AIE dots.72 Block copolymer lipid-PEG was chosen as the 
encapsulation matrix. To form AIE dots, the THF mixture of lipid-PEG and AIEgens 
was added into MilliQ water and followed by the ultrasound sonication. Instead of 
forming micelles, hydrophobic lipid segments intertwine with AIEgens to form the 
compact core while PEG segments extend outside towards water phase to stabilize AIE 
dots. Through controlling the length of PEG segments, the AIE dot sizes can be 
controlled from 30 nm to 100 nm. AIE dot surfaces can also be rendered with different 




Scheme 1.2. A) Chemical structure of TPETPAFN and its emission intensity changes in 
THF/water mixture. B) Schematic illustration of the fabrication of PLGA-PEG-Fol AIE dots 
eccentrically or homogeneously loaded with TPETPAFN.73 Copyright 2012 Wiley-VCH. 
In 2012, Liu’s group reported the emulsion approach to fabricate poly(DL-
lactide-co-glycolide) (PLGA) loaded AIE dots for targeted cellular imaging.73 In this 
method, dichloromethane (DCM) that is immiscible with water was chosen as the 
organic solvent, and polyvinyl alcohol (PVA) was selected as the emulsifier. 2,3-Bis(4-
(phenyl(4-(1,2,2-triphenylvinyl)phenyl)amino)-phenyl)fumaronitrile (TPETPAFN) 
with almost zero fluorescence in THF but largely intensified red fluorescence in 
aggregates was used as the AIEgen (Scheme 1.2A). To fabricate the AIE dots, 
TPETPAFN, PLGA, and poly([lactide-co-glycolide]-b-folate[ethylene glycol]) 
(PLGA-PEG-folate) were fully dissolved in DCM solution, which was further poured 
into aqueous solution containing PVA as the emulsifier, followed by ultrasound 
sonication (Scheme 1.2B). The size of PLGA AIE dots is around 200 nm with high 





eccentrically aggregate at one side of the PLGA dots prepared from low PVA 
concentration (0.25%), while homogeneous distribution of TPETPAFN was observed 
for PLGA dots prepared from high PVA concentration (2.5%). In addition, this 
eccentric aggregation showed higher fluorescence quantum yield (32%) over 
homogeneous distribution (24%), which was utilized for cell imaging applications. 
In 2012, Liu’s group reported the encapsulation AIEgens into protein dots for 
in vitro and in vivo bio-imaging.74 The new AIEgen, 2-(2,6-bis((E)-4-(phenyl(4’-(1,2,2-
triphenylvinyl)-[1,1’-biphenyl]-4-l)amino)styryl)-4H-pyran-4-ylidene)malononitrile 
(TPETPADCM) was encapsulated by bovine serum albumin (BSA) protein. To form 
BSA dots, the THF solution of TPETPADCM was added into BSA aqueous solution. 
Upon mixing, TPETPADCM aggregated and entangled at the hydrophobic parts of 
BSA, and the BSA will gradually undergo phase separation and self-assembly to form 
BSA dots, which were further stabilized via cross-linking by glutaraldehyde. The BSA 
dots showed uniformly distributed spheres with size around 100 nm and high 
fluorescence, suitable for bio-imaging applications.  
Hereafter, various polymeric matrices with different hydrophobicity have been 
developed for encapsulation of AIE aggregates into AIE dots with amendable surface 
functional groups.75-77 This non-covalent encapsulation of AIEgens does not require the 
chemical modification of AIEgens, and the rapid development of polymer materials 
and nanotechnology also further expanded the fabrication methods of AIE dots.  
1.4 AIE Dots for Biological Applications 
Together with the rapid and extensive development of AIE dots, their biological 
applications have been widely investigated and reported by different researchers. 
Different from conventional fluorogen based NPs, which often result in quenched 
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fluorescence due to the notorious ACQ phenomenon, AIE dots with high brightness, 
good photostability, excellent biocompatibility and ease of surface functionalization 
have shown their merits and potentials in different biological applications such as in 
vitro imaging, in vivo imaging and therapy. 
1.4.1 In Vitro Imaging 
The early application of AIE dots in bio-imaging was mainly focused on non-
targeted in vitro cellular imaging. For example, in 2010, Tang and co-authors reported 
the fabrication of fluorescent silica NPs (FSNPs) with controllable size from 50 to 300 
nm. The fluorescence quantum yields of FSNPs increase along with the increase in 
AIEgens loading percentage. The obtained FSNPs could nonspecific internalize into 
living HeLa cells through endocytosis where FSNPs were enclosed by membrane to 
form small vesicles first, followed by internalization and releasing from endosomes and 
lysosomes to cytoplasm (Figure 1.5A).56  Another type of AIE dots prepared by 
polymer encapsulation also has been studied in non-targeted cellular imaging by Jen et 
al.71 In this contribution, HPS-encapsulating PMAA-b-PS micelles showed much 
higher fluorescence in RAW cells while bulk HPS aggregates without block copolymer 
encapsulation did not show significant internalization into cells. These studies clearly 
demonstrated the importance of polymer encapsulation in facilitating the stable 
dispersion of AIE aggregates in biological environment and the enhanced cellular 
internalization. This study also revealed that the hydrophobicity of the chosen block 
copolymer matrix also plays importance roles in determining the brightness and the 




Figure 1.5.  A) Fluorescence image of HeLa cells stained by FSNPs at TPE concentration of 6 
µM.56 B) Two-photon excited fluorescence image of MCF-7 stained by folate functionalized 
AIE dots.72 All the images share the same scale bar of 20 µm. Copyright 2010 Wiley-VCH and 
2011 Royal Society of Chemistry. 
Besides nonspecific cellular imaging, the AIE dot surfaces were further 
functionalized with targeting ligands such as folate or targeting peptides to enhance the 
cellular uptake towards specific cells. One of the particular examples of targeted 
cellular imaging for AIE dots is demonstrated by Liu’s groups in 2011.72 The AIEgen 
with high two-photon absorption (TPA) was encapsulated by 1,2-distearoyl-sn-glycero-
3-phosphoethanolamine-N-[folate(polyethylene glycol)-2000] (DSPE-PEG-Folate), 
the TPA cross section is over 500 GM for the resultant AIE dots, which is higher than 
most water-soluble TPA materials. After 2 h incubation, bright fluorescence was 
observed in the cytoplasm of MCF-7 cells with overexpressed folate receptor (Figure 
1.5B), while only very weak fluorescence was detectable from NIH-3T3 fibroblast cells 
due to the lack of folate receptor at cell surface. In addition, the AIE dots showed low 
cytotoxicity with ~100% cell viability after 72 h incubation. Later in 2012, the same 
groups further studied the uptake mechanism of DSPE-PEG-Folate encapsulated AIE 
dots.78 Blocking the folate receptor by free folic acid or lowering the incubation 
temperature to 4 °C will largely suppress the cellular uptake of AIE-Folate dots, 




series of inhibitors were further applied, which revealed that uptake of AIE-Folate dots 
is mainly involved in caveolae-mediated endocytosis while clathrin-mediate 
endocytosis and micropinocytotsis are not involved. Tang and co-authors also reported 
targeted cellular imaging towards cancer cells with biotin-receptor overexpression 
using biotin decorated silica AIE dots.57 
 
Figure 1.6. A) Chemical structures of 1a and 1b, b) SEM image of 1a aggregates formed in 
THF/water mixture. C) Fluorescence intensities and images of HeLa cell stained by 5 µM of 
1b and 200 nM MTG at different passages (Psg).79 Copyright 2012 Wiley-VCH. 
These optical properties such as high bright, good photostability, low 
cytotoxicity and excellent cellular retention make AIE dots an excellent cell tracker to 
visualize complex biological processes such as proliferation, division, and metastasis 
of cancer cells. The pioneer work of cell tracing with AIE dots was reported by Tang 





for tracing the activity of HeLa cells over four passages.79 The silole derivatives are 
able to self-assemble into dots with size around 300 nm (Figures 1.6B) and quantum 
yield of ~40%. This 1b AIE aggregates showed excellent biocompatibility with ~100% 
cell viability even after incubation at 5 µM, while incubation HeLa cells with the 
commercial available MitoTracker Green (MTG) at 2 µM showed damaged 
mitochondria structures. In addition, the fluorescence intensity of HeLa cells increases 
with the 1b concentration, while using concentrated MTG does not guarantee the high 
brightness. The 1b AIE dots inside HeLa cells firmly retained inside the cytoplasm 
during the cell proliferation and can be passed to daughter cells over four passages, 
while the MTG fluorescence was not detectable even in the 2nd passage (Figure 1.6C).  
AIE dots with longer cell tracing time were further developed by Liu’s group.75, 
76 The DSPE-PEG loaded AIE dots were surface functionalized with cell penetration 
peptide derived from HIV-1 transactivator of transcription (Tat) protein. The Tat 
modified AIE dots showed much improved cellular uptake and retention, which can 
track the cell activity over 10 passages. While commercial QD tracker can only track 
cell activity for 4 passages. Liu’s group also reported the dual colour cell tracing,77 two 
AIE dots with distinct emission spectra can be simultaneously excited by single-
wavelength. Through labelling cells with different emission colours, the cellular 
interactions during cancer metastasis can be clearly visualized.  
1.4.2 In Vivo Imaging 
The development of AIEgens in the far-red/near-infrared (FR/NIR) regions 
further makes them the attractive reagents for in vivo imaging due to their high 
penetration depth, low background signal interference and low photodamage to 




Figure 1.7. A) In vivo non-invasive fluorescence imaging of H22-tumor-bearing mice after 
intravenous injection of TPETPADCM loaded BSA dots. B) Ex vivo fluorescence imaging on 
tumor tissue and major organs of mice treated with BSA dots.74 Copyright 2012 Wiley-VCH. 
The early example of AIE dots for in vivo imaging was demonstrated by Liu 
and Tang et al.74 They encapsulated TPETPADCM into BSA dots. Possessing the 
twisted intramolecular charge transfer (TICT) phenomenon and AIE feature of 
TPETPADCM, the obtained BSA dots showed bright red fluorescence centred at 668 
nm in aqueous solution. Increasing TPETPADCM loading ratio results in increased 
quantum yield which reaches the maximum of 12.5%. The in vivo tumour imaging by 
BSA AIE dots was examined on Murine hepatoma-22 (H22)-transplanted tumor-bearing 
ICR mice through intravenous injection. Intense red fluorescence in the tumour tissue 
was observed at all the imaging times, and at 28 h post-injection, strong fluorescence 
in tumour in sharp contrast to weak fluorescence in other part indicated the promising 





of BSA AIE dots is attributed to the passive tumour targeting EPR effects originated 
from the uniform dot size of 100 nm. The occurrence and disappearance of fluorescence 
in the liver and abdomen area also indicated that BSA AIE dots can be uptaken by the 
reticuloendothelial system (RES) organs, and followed by body clearance through 
biliary pathway. This tumour diagnosis was also demonstrated using ex vivo 
fluorescence imaging, where tumour tissue provided the highest fluorescence as 
compared to other major organs of the scarified mouse (Figure 1.7B). The same group 
further co-encapsulated conjugated polymers, poly[9,9-bis(2-(2-(2-
methoxyethoxy)ethoxy)ethyl)fluorenyldivinylene] (PFV) and TPETPADCM into the 
same BSA dots to utilize the large molecular absorption of PFV and FRET to enhance 
the FR/NIR brightness of the AIE dots for in vivo tumour imaging.80 
The excellent biocompatibility and in vitro cell tracing performance of AIE dots 
also inspired the in vivo tracing applications.76 To demonstrate this, Liu et al. 
encapsulated TPETPAFN by DSPE-PEG to form AIE dots to track the in vivo tumour 
growth (Figure 1.8A). The formed AIE dots showed high brightness with quantum yield 
of 24%, and uniform size of 30 nm. Under single nanoparticle fluorescence imaging, 
the AIE dots showed average 1.18 × 106 counts of photon emitted per 100 s, which is 
4-fold higher than QD655 tracker. TPETPAFN dots showed excellent photostability 
under continuous laser scanning. In addition, different from QDs, TPETPAFN AIE dots 
showed stable fluorescence without intermittency (Figure 1.8B). The AIE dots labelled 
C6 glioma cells were subcutaneously injected into the mice flank. The bright red 
fluorescence originated from AIE dots clearly indicates the location and growth of 
tumour cells in mice body, which is traceable up to 21 day (Figure 1.8C), while in the 
parallel experiment, QD tracker 655 can only trace the tumour growth for 7 day (Figure 
1.8D). This report demonstrated the superior advantage of AIE dots in vivo tumour 
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tracing. In a more recent study, Liu et al. further demonstrated AIE dots for precisely 
long-term tracking of adipose-derived stem cells (ADSCs) and monitoring their 
regenerative capability in an ischemic hind limb bearing mouse model.81 
 
Figure 1.8. A) Schematic illustration of AIE dots. B) Fluorescence time-traces of four 
individual AIE dots with different brightness levels. C) In vivo fluorescence imaging of the 
mouse subcutaneously injected with 1×106 of C6 glioma cells labelled with C) AIE dots, or D) 

















Figure 1.9. 3D reconstructed two-photon fluorescence images of blood vessels in A) brain (0–
425 µm), B) bone marrow (0–108 µm), and C) mouse ear skin (0–132 µm) from the mouse 
injected with BTPEBT AIE dots. All images share the same scale bar of 20 µm.82 Copyright 
2013 Wiley-VCH. 
In addition to one-photon in vivo imaging, the potential of AIE dots as two-
photon fluorescence imaging (TPFI) reagents also has been demonstrated. Liu et al. 
reported the AIE dots encapsulating 4,7-bis[4-(1,2,2-triphenylvinyl)phenyl]benzo-
2,1,3-thiadiazole (BTPEBT) for intravital TPFI of blood vessel.82  The fabricated AIE 
dots showed high quantum yield of 62%, and a high TPA cross section of 1.02 × 105 
GM per dot at 820 nm which is much higher than most commercial available TPFI 
reagents. The AIE dots are further applied in the real-time blood vascular imaging in 
live mice. With the bright green emission of BTPEBT AIE dots under two-photon 
excitation, these small capillaries in the pia mater, microvasculature deep in the brain, 
as well as these blood vascular in skull bone marrow and ear skin of mouse can be 
clearly observed with high resolution (Figure 1.9). Without shown obvious toxicity to 





in vivo visualization not only tumour growth, stem cell regeneration, but also blood 
vessel inside various organs.  
1.4.3 Theranostic Applications 
In addition to imaging, the simultaneous utilization of AIE dots in cancer 
therapy and biological imaging also has been reported in recent years. The pioneer work 
was demonstrated by Prasad et al.. In 2007, Prasad’s reported the BDSA and 2-devinyl-
2-(1-hexyloxyethyl)pyropheophorbide (HPPH) co-encapsulated ORMOSIL dots for 
PDT.55 PDT utilize PSs to produce reactive oxygen species (ROS) that are toxic to 
tumour in the presence of oxygen and light has been served as a promising approach 
for cancer therapy.83 The size of the co-encapsulated ORMOSIL dots is less than 30 
nm, and the fluorescence spectrum of BDSA overlaps well with the absorption 
spectrum of HPPH, which ensures the efficient intra-particle FRET between BDSA and 
HPPH. Upon two-photon excitation, the up-converting energy of NIR light absorbed 
by BDSA can be efficiently transferred to HPPH, which resulted in enhanced singlet 
oxygen generation for photodynamic cancer therapy. The two-photon excitation at NIR 
region also ensures the deep tissue penetration, improving the treatment of deeper 
tumours. However, the conventional PSs still suffered from ACQ effect, which leads to 
largely decreased ROS production at high concentration or in aggregates, which largely 
compromises the PDT efficiency.84-86 Other silica AIE dots also has been reported for 
cancer therapy. In 2013, Wei et al synthesized the fluorescent mesoporous silica AIE 
dots using cationic surfactant cetyltrimethyl ammonium bromide (CTAB) as the 
structure-directed template.60 Since CATA is a broad-spectrum antiseptic agents for 
tumor treatment, the resultant mesoporous silica AIE dots can also serve as an efficient 




Figure 1.10. Confocal fluorescence images of the distribution of TPED (TPE-mPEG 75 µM 
and DOX 5 µM) in MCF-7 cancer cells with different incubation time. All the images share the 
same scale bar of 20 µm.87 Copyright 2014 American Chemistry Society. 
In 2014, Liang and Zou et al. reported the imaging of intracellular anticancer 
drug delivery using AIE micelles.87 In this contribution, TPE was conjugated with a 
hydrophilic arm, amino-methoxypolyethylene glycol (mPEG2000−NH2) to yield TPE-
mPEG. Due to the amphiphilic chemical structure, TPE-mPEG is able to self-assemble 
into micelles (TPEM) in aqueous solution. Benefiting from AIE feature of TPE, these 
30 nm micelles are able to emit strong blue fluorescence under laser excitation, and 
they exhibited much high photostability as compared to fluorescein isothiocyanate 
(FITC), a traditional ACQ fluorogen. These TPE micelles are further utilized as the 
carriers for intracellular delivery of DOX, a commonly used anticancer drug. The DOX-
loaded TPE micelles (TPED) were 30 nm spheres with high encapsulation efficiency 
(98.4%), drug loading percentage (15.4%), and good water dispersion. Upon excitation 
at 330 nm, the blue emission from TPE and the red emission from DOX can be observed, 
where these two channels should provide the opportunity for real time tracing of 
intracellular DOX delivery. Upon incubation MCF-7 breast cancer cells with TPED 




overlapped in the cytoplasm indicating that the DOX is still encapsulated in the micelles. 
After 4 h incubation, most of the red fluorescence is detected in the nucleus, indicating 
the successful release of DOX from TPED micelles to the nucleus. The increased blue 
and red fluorescence also indicate the increased cellular uptake of TPEM along with 
time (Figure 1.10). TPEM micelles showed excellent biocompatibility where almost 
100% cell viability was observed at TPEM concentration of 0.1 mM, while loading 
DOX makes these micelles an efficient anticancer reagent. The decreased half maximal 
inhibitory concentration (IC50) value of TPED (~1.2 µM) as compared to free DOX 
(~3.0 µM) also indicates enhanced anticancer effects by encapsulation DOX with TPE 
micelles due to the enhanced cellular uptake.  
In a more recent study, Liu et al. reported a targeted AIE dots system for targeted 
and real-time tracking of dual-drug delivery.69 In this demonstration, the blue emissive 
TPE molecule was covalently conjugated with two anticancer drugs, cisplatin (Pt) and 
DOX. The conjugate was further modified with cRGD peptide, and the resulted cRGD-
TPE-Pt-DOX is able to selectively accumulate in cancer cells with α3β3 integrin 
overexpression through receptor-mediated endocytosis. The cRGD-TPE-Pt-DOX pro-
drug is able to self-assemble into nanoparticles with size around 120 nm. Due to the 
energy transfer from TPE to DOX, cRGD-TPE-Pt-DOX dots showed negligible blue 
fluorescence but intense red fluorescence under excitation. Due to the reduction regents 
such as ascorbic acid present in cells, both Pt and DOX will be released in the targeted 
cancer cells, which will disconnect the FRET pair of TPE and DOX. Hence the blue 
emission will be observed and intensified in the cytoplasm, and the red emission will 
be accumulated at the nucleus along with the drug release, providing the chance for real 
time tracking of DOX release. Moreover, this covalent connection of dual drugs in one 
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molecule also showed enhanced cancer cell killing performance with synergistic 
combination effects. 
 
Scheme 1.3. Chemical structure of Net-TPE-PEI-DMA and the schematic illustration of it as 
pH-responsive light-up AIE dots for targeted imaging and selective suppression of cancer 
cells.68 Copyright 2015 Royal Society of Chemistry. 
In 2014, Liu and Tang el al. reported pH-responsive light-up AIE dots for 
targeted imaging and selective suppression of cancer cells.68 The AIE probe Net-TPE-
PEI-DMA is able to self-assemble into stable AIE dots with size around 170 nm as 
described in previous sections. The AIE dots initially exhibited negative surface with 
zeta potential of -10 mV. At acid microenvironment (pHe ~6.5), the amide bound 
between the amine groups on PEI and DMA will be cleaved, which will result in Net-
TPS-PEI NPs with positive surface zeta potential of 6 mV, facilitating the cellular 
uptake. In addition, the C=C bonds in DMA can quench the fluorescence of TPS, and 
the clearage of DMA in acid environmental will result in the resume of the TPS 
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fluorescence. Since tumour tissue possesses acidic extracellular microenvironment, the 
Net-TPS-PEI-DMA severed as a pH-responsive light up probe for in vivo targeted 
imaging of cancer cells (Scheme 1.3). In addition, the surface charge switch of AIE 
dots showed significant cytotoxicity to cancer cells, revealing the anticancer effects of 
this kind of AIE dots. 
1.5 Research Objectives 
As a novel generation of fluorescence materials, the discovery and development 
of AIEgens have inspired the innovation of molecular probes and NPs with AIE 
characteristics for biological sensing, detection, imaging, and theranostic applications. 
As compared to AIE-based small molecular probes, the fabrication of AIE dots that 
could fully utilize its largely enhanced bright fluorescence in the aggregate state is a 
more general and feasible approach for imaging related biological applications, which 
has just taken-off. The optical and physical properties of AIE dots can be precisely 
controlled via the chemical structure modification of AIEgens and different dot 
fabrication strategies, which bestow AIE dots promising potentials to fulfil these 
requirements in various biological applications. Moreover, the development of surface 
chemistry also facilitates the conjugation of AIE dots with different targeting moieties 
or biomolecules for targeted or multimodality imaging and other biological applications. 
However, the non-specific cellular imaging has dominated biological applications in 
these initial studies of AIE dots, and limited efforts have been made on the development 
of AIE dots with targeting capabilities, especially with subcellular organelle targeting 
abilities. In addition, the exploration of AIE dots in cancer therapy has been relied on 
other regents to provide therapeutic effects. Although several AIE probes have been 
reported with efficient ROS generation for photodynamic therapy (PDT),52, 88 the 
applications of AIE dots inherently born with therapeutic ability still remain unexplored. 
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As such, this thesis aims to develop a group of highly versatile AIE dots with 
desired optical properties that are ready for in vitro and in vivo bio-imaging, and 
theranostic applications. It firstly aims to develop a general and feasible approach for 
synthesis of AIE dots with amendable surface functional groups. After demonstration 
of AIE dots in cell imaging and tracing, as well as blood vascular leakage detection, 
AIE dots with efficient ROS generation will be investigated, and the intracellular 
localization of AIE dots inside targeted cancer cells and its effects on PDT will be 
further evaluated. 
The specific objectives of this Ph.D. thesis are summarized as follows. 
1. To develop a general and feasible approach to fabricate biocompatible ultra-
bright organic AIE dots with amendable surface functional group in one step 
through a modified nano-precipitation method using encapsulating matrix with 
different terminal functional groups. 
2. To demonstrate the application of AIE dots in in vitro cell labelling and long 
term tracking by introducing specific ligands such as cell penetration peptide to 
AIE dot surface. 
3. To introduce MRI regents gadolinium to AIE dot surface and use it as a dual 
modal toolbox for in vivo imaging of blood vascular leakage under 
inflammation and quantitatively analysis inflammation severity. 
4.  To apply AIE dots inherently born with bright fluorescence and efficient ROS 
generation capability for targeted image-guided cancer photodynamic therapy 
through surface modification with targeting peptide. 
5. To further address the intracellular localization of AIE dots in targeted cells 
such as mitochondria for enhanced photodynamic therapy. 
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1.6 Thesis Outline 
This thesis consists of six chapters. Chapter 1 provides a general research 
background of fluorescence bio-imaging, the progress of AIEgens in literatures and the 
objectives of this Ph.D. project. In Chapter 2, a general and facile strategy to fabricate 
colloidal stable and ultra-bright AIE dots with amendable surface functional groups is 
illustrated, which also provides AIE dots design and functionalization guidelines for 
following chapters. The as-prepared AIE dots are further functionalized with cell 
penetration peptides to enhance cellular uptake and cell retention, which is 
subsequently used for staining different types of cell lines and long term cell tracing 
using GFP transfection method as the benchmark. In Chapter 3, new AIE dots with 
bright fluorescence under two-photon excitation were synthesized, and gadolinium was 
further chelated onto the AIE dots surface for visualization and detection of blood 
vascular permeability change during inflammation or infection. The amount of 
gadolinium in the tissue provides the quantitative analysis of the severity of 
inflammation. Chapter 4 develops AIE dots with bright red fluorescence and efficient 
ROS production under irradiation for image-guided photodynamic therapy. The dot 
surface is conjugated with a specific targeting moiety, cyclic-RGD, to achieve specific 
discrimination and killing of transferrin overexpressed cancer cells. In Chapter 5, 
subsequent efforts were made to address the intracellular localization of AIE dots in 
targeted cells. A general strategy by introduction two different targeting moieties to one 
AIE dot is developed, which showed accumulation in mitochondria of targeted cancer 
cells. With efficient ROS production, the dual targeted AIE dots showed enhanced 
anticancer effects under light irradiation. Chapter 6 concludes the Ph.D. thesis and 









GENERAL STRATEGY OF PREPARING ULTRA-
BRIGHT ORGANIC DOTS WITH AGGREGATION-
INDUCED EMISSION CHARACTERISTICS AS A 





During the past decades, fluorescence bioimaging has been extensively utilized in 
visualizing various biological species and progresses,15-17 such as cell organelles,89, 90 
programmed cell death,91 and cell lineage commitment,92 Among these applications, 
continuous non-invasive cell tracing by fluorescence over a long period of time is 
pivotal to extract critical spatiotemporal cellular information of physiological 
displacement, translocation and the fate of cancer and stem cells. This information 
facilitates the understanding of cancer or stem cell development and intervention, 
providing insights for basic oncological researches and development of preclinical cell 
based therapies.22, 93-95 
As one of the major class of fluorescent materials, green fluorescent protein 
(GFP) and its variants have been widely applied in cell transplantation and tracing.18, 20, 
27, 96, 97 This approach capitalizes on the cells innate machinery to produce proteins and 
requires the reporter gene to be transfected into the cells and subsequently translated 
into fluorescent proteins.20, 21, 98, 99 However, viral transduction by integration of GFP 
gene into cell genome suffers from high cost and safety issues due to the introduction 
of random insertional mutation at integration sites.22, 23, 25, 100 While non-viral plasmid 
transfection by expressing the GFP plasmid directly from the cytoplasm only works 
well for short-lived experiments within couples of days.98, 101 In addition, the non-viral 
method presents low and cell type dependent transfection efficiencies.24 Moreover, the 
time lag between GFP expression and gene introduction can result in an inconsistent 
and sometimes even cyclical net amount of fluorescent signal even when actual 
intracellular plasmid concentration is high.26-28. Therefore, new cell tracking methods 




Direct cell labelling by organic or inorganic nanomaterials for tracing has drawn 
great attentions recently, which is fairly straightforward and does not involve genetic 
modification of the cells.22, 93, 102-105 However, QD based cell trackers contain toxic 
heavy metals, while small organic molecules suffer from small Stokes’ shifts, rapid 
photobleaching and cytoplasm leaking upon cell proliferation.33, 106, 107 Researchers 
recently showed that organic nanoparticles (NPs) possess longer cellular retention time 
and lower exocytosis rate as compared to their discrete molecular counterparts.107, 108 
However, the notorious aggregation-caused quenching (ACQ) effects109 of 
conventional organic molecules often lead to weakened or even annihilated 
fluorescence in NPs. We have recently reported a series of novel organic fluorophores 
with aggregation-induced emission (AIE) characteristics, which are highly emissive 
when aggregated.42, 110-114 Based on these AIE fluorogens (AIEgens), we and others 
have successfully reported light-up probes for bio-sensing, detection, and imaging. 
Recently, several AIEgen based nanoparticles were also reported with high 
fluorescence, excellent photostability and biocompatibility,72, 77, 82, 115 revealing their 
great potentials to overcome the obstacles possessed by the currently used cell trackers 
for cell tracing. 
In this chapter, a facile strategy for fabrication of surface functionalized green 
emissive AIE dots for long-term cell tracing was developed. 4,7-Bis[4-(1,2,2-
triphenylvinyl)phenyl]benzo-2,1,3-thiadiazole (BTPEBT) with strong green emission 
in aggregates was selected as the AIEgen core. A mixture of 1,2-distearoyl-sn-glycero-
3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG2000) and 
its maleimide terminated derivative, DSPE-PEG2000-Mal, was chosen as the 
encapsulation matrices to endow BTPEBT into AIE dots with biocompatibility and 
surface maleimide groups. A cell penetrating peptide derived from HIV-1 transactivator 
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of transcription protein (Tat) was further conjugated to the dot surface to yield AIE-Tat 
dots with high cellular internalization efficiency. The AIE-Tat dots show an emission 
maximum at 547 nm, similar to GFP, but with a high quantum yield of 63%. The AIE-
Tat dots also have stable green fluorescence under different pH conditions or after long 
time incubation in buffer solution for over 10 days. The cell labelling performances of 
the AIE-Tat dots in the in vitro studies were compared to the classical calcium 
phosphate mediated pMAX-GFP transfection method under similar experimental 
conditions. It was found that the AIE-Tat dots have the capability to label all the tested 
human cell lines with ultrahigh brightness and ~100% labelling efficiencies, 
significantly outperforming the GFP plasmid transfection approach which shows varied 
and low GFP labelling efficiencies. Moreover, in the cell tracing experiment, AIE-Tat 
dots are capable to trace the activity of HEK293T cells for over 10 days, while pMAX-
GFP can only trace the cell population for a maximum of 3 days. This successful 
demonstration of the AIE dots for in vitro long-term cell tracing offers new 
opportunities and bright prospects in the areas of cancer research, real-time monitoring 
of stem cell transplantation and other cell-based therapies. 
2.2 Experimental  
2.2.1 Materials 
1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene 
glycol)-2000] (DSPE-PEG2000) and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-
N-[maleimide(polyethylene glycol)-2000] (DSPE-PEG2000-Mal) were purchased from 
Avanti Polar Lipids, Inc. Qtracker® 585 cell labelling kit was purchased from Life 
Technologies, Invitrogen, Singapore. Fluoromount® aqueous mounting medium, 
Dulbecco's Modified Eagle Medium (DMEM), tetrahydrofuran (THF), 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), penicillin-
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streptomycin solution, fetal bovine serum (FBS) and trypsin-EDTA solution were 
purchased from Sigma-Aldrich. Cell penetrating peptide derived from transactivator of 
transcription proteins, HIV-1 Tat (49-57) with C-terminus modified with cysteine 
(RKKRRQRRRC), was a commercial product customized by GenicBio, China. Milli-
Q water was supplied by Milli-Q Plus System (Millipore Corporation, Breford, USA). 
2.2.2 Fabrication of AIE Dots 
BTPEBT was synthesized by Dr. Liu Jie according to literature.82, 116 To 
synthesize AIE dots, a THF solution (1 mL) containing BTPEBT (0.5 mg) and DSPE-
PEG2000 (0.5 mg) and DSPE-PEG2000-Mal (0.5 mg) was poured into water (10 mL) 
under sonication using a microtip probe sonicator at 12 W output (XL2000, Misonix 
Incorporated, NY). The mixture was further placed in dark in fume hood for THF 
evaporation at 600 rpm overnight. The AIE dot suspension was further purified by 
filtering through a 0.2 µm syringe driven filter 
2.2.3 Fabrication of AIE-Tat Dots 
Tat was conjugated to AIE dots surface through the efficient click reaction 
between the thiol group on Tat and the maleimide group on AIE dot surfaces. The AIE 
dots (1.8 mL) was mixed and reacted with Tat peptide (3 ×10-5 M, in DMSO). After 
reaction for 4 h at room temperature, the solution was dialysed against MilliQ water 
using membrane with cut-off of 6-8 kDa for 2 days to eliminate the excess peptide and 
DMSO. The AIE-Tat dots were filtered through 0.2 µm syringe filter and collected for 
further use. 
2.2.4 Characterization 
UV-vis spectra were recorded on a Shimadzu UV-1700 spectrometer. 
Photoluminescence (PL) spectra were recorded on a Perkin-Elmer LS 55 
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spectrafluorometer. Average particle size and size distribution of the samples were 
measured by laser light scattering (LLS) with a particle size analyser (90 Plus, 
Brookhaven Instruments Co. USA) at a fixed angle of 90° at room temperature. The 
morphology of the samples was studied by high resolution transmission electron 
microscopy (HR-TEM, JEM-2010F, JEOL, Japan). 
2.2.5 Calculation of AIE Dot Concentration 
Freeze-drying of the AIE-Tat dot stock solution (2 mL) yielded 0.34 mg of 
powders. As the AIE-Tat dots are stable in water, the density of the dot suspension 
could be estimated as ~1 g/cm3. As the average size of AIE-Tat dots determined from 
HR-TEM is ~30 nm, the concentration of the AIE-Tat dots in stock can be calculated 
from the following equation:  
 
Finally, the concentration of AIE-Tat dots in stock solution was calculated as 
following: 
 
2.2.6 Single Particle Fluorescence Imaging 
Fluorescence imaging of individual AIE-Tat dot was performed with a custom-
built Wide-Field Microscope (WFM) based on a Nikon ECLIPSE Ti-U inverted 
microscope frame. Light from a CW multi-line Ar ion laser (Melles Griot, CA, USA) 
was ﬁber-coupled to a Nikon TIRF attachment and focused on the back aperture of a 
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(nD = 1.4790, Cargille, USA) was added between the high NA objective and the cover 
slip for index matching. The luminescence was collected by the same objective. After 
passing through the dichroic mirror and the emission filter, the luminescence was 
directed onto an iXonEM+897 EMCCD camera (512 × 512 pixels, 150 nm per pixel 
resolution, Andor Technology, Northern Ireland) connected to the side port of the 
microscope. A filter set consisting of a z488/10× excitation filter, Z488RDC dichroic 
mirror, and HQ500LP emission filter was used for imaging. The camera was connected 
to a computer furbished with camera-dedicated software to control the imaging 
parameters, and for data acquisition. The samples were prepared by depositing a droplet 
of NP solutions on a glass cover slide, waiting for 30s for particles adsorption to the 
substrate, removing excess of liquid and drying under N2. Fluorescence intensity time-
traces were obtained by acquiring 1000 consecutive frames at a rate of 10 frames per 
second (100 ms exposure time, 100 s time-traces) and extracting the number of counts 
per particle at each frame. The images were analysed using Andor Solis (ver. 
4.14.30001.0, Andor Technology, Northern Ireland) and NIS Elements Ar 4.10.00 
(Nikon, Japan) software. The fluorescence intensity time-traces were analyzed by 
subtracting the background and integrating all the remaining photon counts using a 
customized analysis software written in LabView (National Instruments). 
2.2.7 Cell Culture 
Human colon adenocarcinoma SW480 cells, human colon adenocarcinoma 
DLD-1 cells, normal human colon mucosal epithelial NCM460 cells, normal-human 
primary dermal fibroblast (NHDF) cells, and human embryonic kidney 293T (HEK 
293T), and human bone marrow derived stem cells (BMSCs) (ATTC, USA) cells were 
cultured in Dulvecco's modified Eagle's medium (DMEM) supplemented with 10% 
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fetal bovine serum (FBS) and 1% penicillin/streptomycin solution. Cell culture was 
maintenance at 37 °C under humidified air containing 5% CO2. 
2.2.8 Cell Labelling by AIE-Tat Dots 
HEK 293T cells were cultured in chamber (LAB-TEK, Chambered Coverglass 
System) at 37 ºC. After 80% confluence, the medium was removed; the adherent cells 
were washed twice with 1× PBS buffer. AIE-Tat dots with different concentrations (1 
pM, 5 pM, 10 pM, 200 pM, 1 nM, and 2 nM) suspended in cell culture medium were 
then added into the chamber. After 2 h incubation, the cells were washed twice with 1× 
PBS buffer. To label lysosome, the cells were further incubated with LysoTracker Red 
DND-99 (Life Technology, 75 nM) for 30 min. After washing twice with 1× PBS 
buffer, the cells were immediately imaged by confocal laser scanning microscope 
(CLSM). For comparison with GFP transfection method, SW480, DLD-1, NCM460, 
NHDF cells, and HEK293T cells were cultured in 6-well plate. After 80% confluence, 
the adherent cells were washed twice with 1× PBS, AIE-Tat dots (2 nM) suspended in 
cell culture media were then added into each well. After overnight incubation, the cells 
were washed twice with 1×  PBS buffer, trypsinalized and then analyzed by flow 
cytometry measurements using Cyan-LX (DakoCytomation) and the histogram of each 
sample was obtained by counting 10,000 events. For confocal image studies, the cells 
were cultured in a 6-well plate containing cell culture coverslip. After being labeled by 
2 nM AIE-Tat dots, the cells were washed twice with 1× PBS buffer and then fixed by 
4% formaldehyde for 20 minutes. The coverslips were sealed with mounting medium 
and the fluorescence images were studied by CLSM. To study cell retention of AIE-Tat 
dots, two groups of HEK293T cells were used. The sample group was incubated with 
2 nM AIE-Tat dots overnight at 37 oC while the control group remains untreated. After 
incubation and detachment, 2 mL of AIE-Tat-stained cells and 2 mL of control cells 
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with the same density (40000 cells/mL) were mixed and subcultured in culture flasks 
for 2 days. Meanwhile, the control and sample cells were also subcultured for 2 day. 
The three batches of cells were then trypsinalized and tested using flow cytometry. In 
all flow cytometry tests, blank cells without any treatment were used as the control.  
2.2.9 Cytotoxicity of AIE-Tat Dots 
Methylthiazolyldiphenyltetrazolium bromide (MTT) assay was used to evaluate 
the metabolic activity of HEK 293T cells. HEK 293T cells were seeded in 96-well 
plates (Costar, IL, USA) at a density of 4 × 104 cells/mL, respectively. After 24 h 
incubation, the old medium was replaced by AIE-Tat dots suspension at concentrations 
of 2, 5, and 10 nM, and the cells were then incubated for 24 h and 48 h, respectively. 
The wells were then washed with 1× PBS buffer and 100 µL of freshly prepared MTT 
(0.5 mg/mL) solution in culture medium was added into each well. The MTT medium 
solution was carefully removed after 3 h incubation. Filtered DMSO (100 µL) was then 
added into each well and the plate was gently shaken for 10 min at room temperature 
to dissolve all the precipitates formed. The absorbance of MTT at 570 nm was 
monitored by a microplate reader (Genios Tecan). Cell viability was expressed by the 
ratio of the absorbance of the cells incubated with AIE-Tat dots to that of the cells 
incubated with culture medium only. 
2.2.10 Cell Labelling by GFP 
  HEK 293T, SW480, DLD-1, NCM460, and NHDF and BMSCs were grown to 
80% confluence in a 6-well plate format prior to transfection. Standard calcium 
phosphate transfection method was employed to transfect the cells with the pMAX-
GFP plasmid (5 µg/ well, Amaxa Biosystems, USA), that drives the expression of the 
GFP from copepod Pontellina p.  Briefly, HEPES buffer solution was added to the 
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plasmid DNA in CaCl2 solution (250 mM) while vortexing and the mixture was allowed 
to stand at room temperature for 5 min. Transfection mixture was then added dropwise 
to the chamber and incubated overnight before the cells were washed three time with 
1 ×  PBS buffer and trypsinalized. The fluorescence intensities of cells were then 
analyzed by flow cytometry measurements using Cyan-LX (DakoCytomation). The 
histogram of each sample was obtained by counting 10,000 events. For confocal image 
studies, the cells were cultured in 6-well plate containing cell culture coverslip. After 
being labeled by pMAX-GFP, the cells were washed twice with 1× PBS buffer and 
then fixed by 4% formaldehyde for 20 minutes. The coverslips were sealed with 
mounting medium and the fluorescence images were studied by CLSM.  
2.2.11 In Vitro Cell Tracing 
The HEK 293T cells were cultured in 6-well plates. After reaching 80% 
confluence, the cells were labeled by AIE-Tat dots or transfected by pMAX-GFP 
plasmid. After labeling, the cells were diluted in to 6-well plates for designated times 
(1 to 12 days with an interval of 1 day). After designated time intervals, the cells were 
washed twice with 1× PBS buffer and then trypsinalized to suspend in 1× PBS buffer. 
The fluorescence intensities of cells were then analyzed by flow cytometry. For 
confocal image studies, the labeled cells were diluted in 6-well plates containing cell 
culture coverslips for designated time intervals. Upon reaching the time interval, the 
cells were washed twice with 1× PBS buffer and then fixed by 4% formaldehyde for 
20 minutes. The coverslips were sealed with mounting medium and the fluorescence 
images were studied by CLSM. The laser at 514 nm was adopted to obtain the one-
photon excited fluorescence images with a 550–780 nm bandpass filter. 
 44 
 
2.3 Results and Discussion 
2.3.1 Fabrication of AIE-Tat Dots 
 
Scheme 2.1. A) Chemical structures of BTPEBT, DSPE-PEG2000, and DSPE-PEG2000-Mal. B) 
Schematic illustration of AIE-Tat dots formation. 
To demonstrate the fabrication of AIE dots, BPTEBT (Scheme 2.1A) was 
selected and synthesized via Suzuki coupling reaction according to previous report.82, 
116 The AIE effect of BTPEBT was studied by measuring its photoluminescence (PL) 
spectra in tetrahydrofuran (THF)/water mixture with different water fraction (fw). Along 
with increasing fw, BTPEBT initially showed gradually quenched fluorescence, 
followed by fluorescence recovery (Figure 2.1). The fluorescence quenching represents 
twisted intramolecular charge transfer (TICT) caused by solvent polarity increase due 
to the donor and accepter structure of BTPEBT.117 Upon further increasing fw to 50% 
or high, BTPEBT started to form nano-aggregates, which is companied with the 
fluorescence recovery, indicating that AIE plays the dominant role for the bright 
fluorescence in aggregate state. Such a special molecular structure makes BTPEBT a 












Figure 2.1. PL spectra of BTPEBT in THF/water mixtures with various water fractions, (A) fw 
= 0 to 50 vol%, (B) fw = 50 to 90 vol%. [BTPEBT] = 10 µM, λex = 422 nm. 
A modified nano-precipitation method is applied to fabricate the ultra-bright 
and biocompatible BTPEBT-loaded AIE dots. 1,2-Distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxyl-(polyethylene glycol)-2000] (DSPE-PEG2000) and 
its maleimide ended derivative, namely DSPE-PEG2000-Mal (Scheme 2.1A), were used 
as the encapsulation matrices to embed BTPEBT into the core of resultant AIE dots. 
Scheme 2.1B shows the schematic illustration of BTPEBT-loaded AIE dots formation, 
which is achieved by dropwise addition of the THF mixture of matrix polymer and 
BTPEBT into MilliQ water under ultrasound sonication. During the mixing and 
sonication, the hydrophobic DSPE segments will intertwine with BTPEBT molecules 
to form the core, and hydrophilic PEG chains extend towards aqueous phase to prevent 
AIE dots from further aggregation. The ultrasound energy will prevent the formation 
of large aggregates. The presence of PEG shells further stabilized the AIE dots by 
forming the protective shells. The PEG shells also minimize their nonspecific 
interaction with biological species and help provide functional groups for further 
chemical or biological conjugation. After THF evaporation, a cysteine modified cell 
membrane penetration peptide (RKKRRQRRRC) derived from HIV-1 transactivator 









































(Tat) of transcription protein118, 119 was conjugated onto AIE dots through click reaction 
between surface maleimide and the thiol groups of the peptide to yield AIE-Tat dots. 
2.3.2 Characterization of AIE-Tat Dots 
 
Figure 2.2. (A) LLS result of AIE-Tat dots in aqueous solution, inset is TEM image of AIE-
Tat dots. (B) Hydrodynamic diameter changes of AIE-Tat dots upon continuous incubation in 
1×PBS at 37 oC for 10 days. (C) Absorption and PL spectra of AIE-Tat dots in water at room 
temperature. (D) PL intensity changes of AIE-Tat dots at 547 nm in water at different pH. λex 
= 420 nm. 
Laser light scattering (LLS) was applied to study the size distribution of AIE-
Tat dots, which revealed an average hydrodynamic diameters 33.9 ± 1.4 nm, with 
narrow size distribution and a polydispersity of ~0.10 (Figure 2.2A). The AIE-Tat dots 
are spherical with a diameter of ~30 nm under transmission electron microscopy (TEM) 
(Figure 2.2A, inset). It should be noted that the AIE dots are compact packed rather 
than forming micelles, as evidenced by the black dots in TEM due to high electron 






































































































with water.  The colloidal stability of AIE-Tat dots in biological environment was also 
studied by incubating the AIE-Tat dots in 1× phosphate buffered saline (PBS) at 37 ºC 
for ten days. LLS results showed similar hydrodynamic diameters within the tested 
period (Figure 2.2B). Moreover, the AIE-Tat dots suspension remained clear and no 
precipitation was observed after storage for 3 month, indicating high colloidal stability.  
Figure 2.2C shows the UV-vis and PL spectra of AIE-Tat dots in aqueous 
suspension. The AIE-Tat dots have two absorption peaks centred at 318 and 422 nm, 
with a molar extinction coefficient of 5.9 × 107 M-1cm-1 at 422 nm on the basis of dot 
concentration. The AIE-Tat dots show an emission maximum at 547 nm, with a large 
Stokes shift of 125 nm and a high fluorescence quantum yield of 63  2%, measured 
using Rhodamine 6G in methanol as the standard (quantum yield = 93%). The high 
quantum yield arises from the AIE feature of BTPEBT, where BTPEBT fluorogens 
form strong emissive aggregates in the NPs. Such a large Stokes shift should minimize 
the signal interference from excitation laser source. It should be the AIE-Tat dots 
exhibited high resistance to surrounding environment pH changes, where the brightness 





Figure 2.3. (A) Representative wide field fluorescence image of individual AIE-Tat dots. (B) 
Corresponding fluorescence intensity histogram of AIE-Tat dots (1338 dots) emitted during 
100s. (C) Fluorescence changes of individual AIE-Tat dots after 100s laser scanning. 
Wide-field fluorescence microscopy was further applied to evaluate the 
photophysical properties of individual AIE-Tat dots. Figure 2.3A represents a 
luminescence image of individual AIE-Tat dots under 488 nm laser excitation, and 
Figure 2.3B summarizes the corresponding histograms of total number of photons 
emitted by these 1388 representative AIE-Tat dots within 100s. The AIE-Tat dots show 
an average emitted photon number of 6.07× 105 counts under excitation of 488 nm 
laser, indicating the high brightness of AIE-Tat dots, which is much higher than QD 
Tracker 585. Photo-bleaching of the representative dots is shown in Figure 2.3C, by 
plotting the final intensity of each dot after 100s exposure versus its initial intensity. 
The extent of difference would give the magnitude of photobleaching. A line with a 
slope of 1 is drawn as reference, representing no change in the intensity within 100s. 










































The dots lying close to or above the reference line are considered as non-bleaching due 
to the inevitable intensity signal fluctuation. Even though some dots become slightly 
faded, the majority lies around the diagonal line, indicating high photostability of the 
AIE-Tat dots.  
In addition, the fluorescence intensity changes of individual AIE dots under 
continuous excitation for 100 s were also studied. Figure 2.4 shows representative 
fluorescence intensity time-traces of two individual AIE-Tat dots and two QD tracker 
585. It is observed that AIE dots have stable fluorescence within the test period, without 
intermittency, known as characteristic blinking for QDs. This offers great advantages 
and opportunities for AIE-Tat dots in real-time single dot tracing studies. 
 
Figure 2.4. Representative fluorescence time traces of A) two AIE-Tat dots and B) two QD 
Tracker 585 within 100s. 
 












































2.3.3 In Vitro Cellular Imaging by AIE-Tat Dots 
 
Figure 2.5. CLSM images of HEK 293T cells after incubation with AIE-Tat dots at different 
concentrations for 2 h. All the images share the same scale bar of 30 µm. 
The in vitro cellular imaging performance of AIE-Tat dots was evaluated using 
human embryonic kidney 293T (HEK 293T) cells as a model. AIE-Tat dots are 
passively loaded into adherent HEK 293T cells by incubating them with AIE-Tat dots 
at different concentrations (0 to 2 nM). After 2 h incubation, the fluorescence images 
of HEK 293T cells were examined using CLSM with emission signal collected above 
505 nm upon excitation at 488 nm. A progressive increase in green fluorescent signal 
from the cellular membrane to cytoplasm was observed along with increase in AIE-Tat 
dots concentrations (Figure 2.5). At low AIE-Tat dot concentration of 50 pM or lower, 
the AIE-Tat dots tend to bind to cell membrane, whereas negligble fluorescence was 
detected from the cytoplasm. However, at an incubation concentraion of 2 nM, the 
accumulation of green fluorescence in the cytoplasm is clearly observed. These results 










in two stages: binding to membrane surface before a threshold surface coverage is 
reached, followed by disintegration of membrane and internalization into the 
cytoplasm.118 While without Tat functionalization, the AIE dots can hardly internalize 
into cells, where only very weak fluorescence can be observed inside HEK 293T cells 
(Figure 2.6). This is due to the suppressed nonspecific internalization by the presence 
of PEG protective shells, which also indicates that this formulation can be further 
functionalized with specific targeting ligands for targeted cellular imaging with high 
selectivity and sensitivity. 
 
Figure 2.6. A) Fluorescence, B) white field, and C) fluorescence/white field overlay images of 
HEK 293T cell after 2 h incubation with AIE dots (2 nM). 
The HEK 293T cells were further co-stained with LysoTracker Red DND-99 
which selectively stains the lysosomes to determine the subcellular distribution of AIE-
Tat dots. The results are shown in Figure 2.7A, besides labelling the lysosome vesicles, 
the AIE-Tat dots are also able to stain almost everywhere else in the cytoplasm, 
providing insights into the sub-cellular distribution of the AIE-Tat dots. In addition, 3D 
fluorescence image of HEK 293T cell revealed a homogeneous distribution of AIE-Tat 
dots inside the cells (Figure 2.7B). This indicates the excellent colloidal stability of 
AIE-Tat dots in the cytoplasm, which promotes the equal distribution of AIE-Tat dots 
in daughter cells during cell division. Moreover, we also mixed equal number of 
unstained HEK 293T cells with AIE-Tat dots labelled cells. After 2 days co-culture, the 
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mixed cells showed similar flow cytometric spectrum to that of AIE-Tat dots labelled 
cells (Figure 2.7C), indicating the high cell retention of AIE-Tat dots during cell 
proliferation. The equal distribution of positively stained and negative stained cells also 
hints that cell cycle is not affected by AIE-Tat dots. These properties are highly 
promising for long term tracking of cell migration, among other tracing related 
applications.  
 
Figure 2.7. (A) CLSM images of HEK 293T cells after incubation with AIE-Tat dots (2 nM, 2 
h) and Lysotracker Red DND-99 (75 nM, 30 min) in sequence. (B) 3D CLSM image of AIE-
Tat dots treated HEK 293T cells. (C) Flow cytometry histograms of HEK293T cells stained by 
2 nM AIE-Tat dots at 37 oC for 24 h (red line), unstained cells (black line) and a mixture of 
AIE-Tat dot-stained HEK293T cells and unstained cells (1:1; blue line) after 2 days co-culture. 
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2.3.4 In Vitro Cell Labelling Comparison between GFP and AIE-Tat Dots 
 
Figure 2.8. (A) Flow cytometry histograms of different cell lines after pMAX-GFP expression 
(red lines), AIE-Tat dots staining (blue lines) or without any treatment (black lines).  
Next, the application of AIE-Tat dots as a generic labelling agent was further 
examined using a panel of human cells of different tissue origin. HEK 293T cells, 
human colon adenocarcinoma SW480 cells (SW480), human colon adenocarcinoma 
DLD-1 cells (DLD-1), normal human colon mucosal epithelial cells (NCM460 cells), 
normal human primary dermal fibroblast cells (NHDF cells), and human bone marrow 
derived stem cells (BMSCs) were chosen as in vitro model cell lines. Calcium 
phosphate transfection method was employed as a standard benchmark to transfect 
these cells to express GFP.120 pMAX-GFP plasmid (5 µg/ well) that drives the GFP 
expression from copepod Pontellina p. was incubated with the cells overnight. Similar 
procedures were also repeated for cells to be labeled by AIE-Tat dots (2 nM). The 
labeling efficiencies by GFP or AIE-Tat dots are assessed by means of flow cytometry 
analysis. Figure 2.8 shows the fluorescence profiles of these cell lines. Among the cells 
tested, only HEK 293T cells display relative high GFP expression, while SW480, DLD-







































































mean fluorescence, which falls just above the cell auto-fluorescence profile. These 
results are similar to literature reports, where non-viral transfection methods present 
relatively low and cell type dependent transfection24, 25. On the contrary, AIE-Tat dots 
showed nearly 100% labeling efficiencies towards all the tested cell lines, with over 
100-fold higher mean fluorescence intensity as compared to GFP labeled cells.  
 
Figure 2.9. Fluorescence/transmission overlay images of pMAX-GFP expressed cells and AIE-
Tat dots labelled cells. Insets are labelling rates measured by flow cytometry. All the images 
share the same scale bar. 
This results were further confirmed by CLSM images (Figure 2.9), where only 
few cells were lighted up by GFP for most of these cell lines, indicating the the 
limitation of GFP transfection method in practical applications. Among them, HEK 
293T showed the highest GFP labelling rate of 70%, which is still not satisfied for long 
term cell tracing. On the other hand, all the cells treated with AIE-Tat dots showed 
bright green fluorescence, despite of cell types, indicating that Tat functionalized AIE 
dots are able to internalized into most type of cells, even primary cells, and stem cells . 
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immediately detected by CLSM and flow cytometry, while a lag period of several to 24 
hours between plasmid introduction and GFP expression exists for GFP transfection, 
further revealing the advantage of AIE dots as imaging contrast over GFP. 
 
Figure 2.10. A) Photostability of AIE-Tat dots and GFP in HEK293T cells. B) Cell viability 
of HEK293T cells after incubation with AIE-Tat dots at different concentrations for 24 and 48 
h, respectively. 
In addition, AIE-Tat dots showed higher photostability inside the cells, where 
the signal loss of AIE-Tat dots-staining cells is less than 15%, while GFP transfected 
cells lost 40% of their fluorescence after 10 min of continuous laser scanning (Figure 
2.10A). As biocompatibility of fluorescent materials is of high importance, the 
metabolic viability of HEK293T cells after treatment with AIE-Tat dots was examined 
by methylthiazolyldiphenyltetrazolium bromide (MTT) assays. The HEK 293T cells 
show over 95% cell viability even after 48 h incubation with 10 nM AIE-Tat dots (5-
fold higher concentration than that used for imaging), indicating their excellent 
biocompatibility and very low cytotoxicity (Figure 2.10B).  Collectively, these results 
suggest that our AIE-Tat dots outperform the traditional fluorescent protein-based live 
cell labelling on several fronts, thus making them a promising choice for cell imaging 
and tracing. 






































2.3.5 In Vitro Long Term Cell Tracing 
 
Figure 2.11. (A) Continuous monitoring of cell labelling rates by GFP or AIE-Tat dots for 10 
days. (B) and (C) Flow cytometry histograms of HEK 293T cells after incubation with (B) 2 
nM AIE-Tat dots or (C) 5 µg/well p-MAX-GFP plasmid overnight and then sub-cultured for 
designated times. (D) and (E) CLSM images of HEK293T cells labelled by (D) AIE-Tat dots 
or (E) pMAX-GFP at different days post-incubation. All the images share the same scale bar. 
The ability to achieve long term live cell tracking is indispensable for studies of 
cell migration, chemotaxis, proliferation and differentiation, among other fundamental 
biological processes. Due to the display of high GFP transfection efficiency, HEK 293T 




















































































between AIE-Tat dots and pMAX-GFP. After overnight incubation with AIE-Tat dots 
or GFP plasmid, these cells were subcultured for designated time intervals. The 
fluorescence profiles and labeling rates by the two methods were accessed by flow 
cytometry, and the results are shown in Figure 2.11. AIE-Tat dots labeled HEK293T 
cells show 99.98% labeling efficiency at 1st day after incubation, which remains above 
90% on the 5th day of post-incubation (Figure 2.11B). After 10 days of continuous cell 
culture, the cell labeling rate drops to 20%, while clearly distinguishable fluorescence 
profile from untreated cells was still observed. On the other hand, due to the existence 
of signal lag period (Figure 2.11A), the brightest GFP signal was observed on the 3rd 
day after plasmid introduction, which was defined as the 1st day for cell tracing. The 
highest GFP labeling rate is 68% on the 1st day, with only 3-fold higher mean 
fluorescence intensity than blank HEK 293T cells (Figure 2.11C). On the 5th and 10th 
days of post-incubation, the GFP-positive cells are only around 30% and 4%, 
respectively. The confocal images were also provided to further confirm their cell 
tracing performance. Over half cells showed bright GFP fluorescence on the first two 
days, but only a few cells show GFP fluorescence on the 3rd and 5th day (Figure 2.11E). 
From 7th day onwards, no GFP-positive cell can be observed. AIE-Tat dots labeled cells 
still show bright fluorescence for almost all the cells at 7th day of post-incubation, and 
the signal is traceable in some cells on the 10th day (Figure 2.11D). The high brightness 
and long cell tracing period indicate that AIE-Tat dots can be efficiently internalized 
into cell cytoplasm with high cytoplasm retention ability and is able to pass to daughter 
cells during cell proliferation. 
2.4 Conclusion 
In summary, we successfully fabricated BTPEBT-loaded organic AIE dots 
conjugated with surface cell penetration peptides (HIV-1 Tat) (AIE-Tat), and 
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demonstrated their applications of non-invasive in vitro cell imaging and tracing. 
Benefitting from the AIE nature of BTPEBT, the AIE-Tat dots showed ultra-bright and 
stable fluorescence under different pH conditions and upon continuous laser scanning. 
In vitro cellular imaging study reveals an extremely low working condition of 200 pM 
for cell labelling purpose, and an excellent colloidal stability and even distribution of 
AIE-Tat dots in cell cytoplasm with excellent cell retention. In addition, AIE-Tat dots 
showed successful internalization into all tested six different human cell lines including 
stem cells all with ~100% labelling efficiencies, superior over the commonly used 
calcium phosphate mediated GFP transfection method where only HEK 293T cells 
showed a high GFP labelling rate of ~70%. The cell tracing experiments further 
revealed that the internalized AIE-Tat dots could be efficiently transferred to daughter 
cells during cell proliferation and trace HEK 293T cells up to 10 days (equivalent of 14 
generations) with almost 100% cell labelling rate within the first 5 days, outperforming 
GFP plasmid transfection method. This study clearly demonstrated the promising 
performance of AIE-Tat dots as directed labelling agents for long term cell tracing, 
which should open new opportunities for oncology studies and cell based therapy. 
Moreover, AIE dots are capable of conjugation with different targeting moieties and 
other imaging modalities such as magnetic resonance and nuclear imaging agents, 












MULITMODAL DETECTION OF VASCULAR 
INTEGRITY AND LEAKAGE BY GADOLINIUM 







Inflammatory reactions are common pathophysiological processes involved in 
innumerable diseases, atherosclerotic plaque development as well asbiological 
implants.73, 121-123 For example, dengue inflammation is the most important mosquito-
borne disease which could lead to fatal dengue shock syndrome, brain inflammation 
could lead to early brain injury and even life-threaten aneurysmal subarachnoid 
hemorrhage (SAH),123 while lung inflammation could result in chronic obstructive 
pulmonary disease and asthma.124 A method or agents that could accurately and reliably 
visualize and determine the acute, localization and severity of infection and 
inflammation is of great clinical importance for rapid initiation appropriate treatment, 
delineation. Several imaging techniques such as magnetic resonance imaging (MRI),125 
positron emission tomography126, 127 or ultrasonography128 have been developed for 
inflammation detection and quantification.129 However, these techniques rely on 
morphologic or metabolic changes and cannot be able to accurately identify acute and 
localized inflammation in the early stage.130  
The blood vessels serve as a physical barrier and function in a highly responsive 
and dynamic manner, allowing rapid control of the transport rate of solutes, 
macromolecules and leukocytes between blood and tissue.130, 131 The regulation of 
vascular permeability is a highly coordinated process that is fundamental for the 
maintenance of homeostasis in the body. While this regulation is important for the 
initiation and resolution of immune responses as well as for tissue repair, the loss of 
barrier function and increase of vascular leakage are often associated with the 
pathogenesis of inflammatory diseases. Although early recognition of vascular leakage 
has been adopted by the WHO as a guideline to identify patients that are at risk of 
developing severe dengue, there are no effective diagnostic and predictive measures for 
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this purpose. Thus, there is an urgent need for a standardized approach to examine 
vascular leakage for risk prediction in dengue infections and other inflammations. It 
also has been reported that Evans blue could bind to albumin in the blood, which can 
served as a marker for detection of vascular permeability by measuring its absorbance 
at 620 nm.132-134 The discovery of red fluorescence of Evans blue under excitation and 
the development of two-photon fluorescence imaging (TPFI) technique further make it 
possible for visualizing the in vivo leakage process.135, 136 TPFI utilizes the low-energy 
irradiation in the near-infrared (NIR) region (700-1000 nm) as the excitation source, 
which has high tissue penetration depth and low auto fluorescence interference.82  
However, the inevitable leakage of Evan blue in normal blood vascular makes it 
difficult to quantitatively determine the leakage severity, and fluorescence of such small 
molecules are largely affected by surrounding environment, further lowering its 
detection sensitivity. 
The discovery of fluorogens with aggregation-induced emission characteristics 
(AIEgens) provided the exciting opportunities for fabrication of organic dots (AIE dots) 
with ultrahigh brightness for biological applications.39, 42, 53 In previous chapter, we 
have successfully demonstrated the (1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N- [methyl(polyethylene glycol)-2000]) (DSPE-PEG2000) 
encapsulated AIE dots showed ultrahigh brightness and excellent stability. In addition, 
the existence of PEG protective shells prevent the nonspecific interaction with 
surrounding biomolecules or proteins, which further inspired us to fabricate AIE dots 
for in vivo biological applications. Herein, in this chapter, we reported a multimodality 
fluorescent toolbox for the assessment of vascular leakage in a preclinical mouse model 
of inflammation. DSPE-PEG with amine terminal groups was used to encapsulate a 
new AIEgen with strong red emission in aggregated state, 2,3-bis(4-(phenyl(4-(1,2,2-
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triphenylvinyl)phenyl)amino)phenyl)furmaronitrile (TPETPAFN), to form the AIE 
dots. AIE dots were further surface functionalized with gadolinium (Gd), the resultant 
AIE-Gd dots showed ultra-bright and stable fluorescence in aqueous buffer solution. 
These AIE-Gd dots also showed excellent colloidal stability, photostability and high 
two-photon absorption. The Gd content can be precisely quantified by ICP-MS at ppb 
level, which should provide the severity of leakage with high sensitivity. We 
demonstrated that these hybrid dots are able to leak outside from blood vessel upon 
inflammation. Using these novel tools based on organic-inorganic hybrid AIE dots, we 
aim to better understand inflammation induced vascular leakage, and to explore the 
possibility to translate these probes into clinical applications for early diagnosis of 
vascular leakage. 
3.2 Experimental  
3.2.1 Materials  
1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene 
glycol)-2000] (DSPE-PEG2000-NH2) was a commercial product of Avanti Polar Lipids, 
Inc. Gadolinium(III) chloride hexahydrate and N,N-dimethylformamide (DMF) was 
purchased from Sigma. 2,2',2''-(10-(2-((2,5-dioxopyrrolidin-1-yl)oxy)-2-oxoethyl)-
1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid (DOTA-NHS-ester) was 
purchased from CheMatech. Tetrahydrofuran (THF) was distilled from sodium 
benzophenone ketyl under dry nitrogen immediately prior to use. All reactions and 
manipulations were carried out under nitrogen gas with the use of standard inert 
atmosphere. Milli-Q water was supplied by Milli-Q Plus System (Millipore 
Corporation, Breford, USA). Ultrapure grade 10×phosphate-buffered saline (PBS) 




NMR spectra were measured on a Bruker AV 500 NMR spectrometer (DRX 
500, 500 MHz). UV-vis spectra were recorded on a Shimadzu UV-1700 spectrometer. 
Photoluminescence (PL) spectra were recorded on a Perkin-Elmer LS 55 
spectrofluorometer. Average particle size and size distribution of the samples were 
measured by laser light scattering (LLS) with a particle size analyzer (90 Plus, 
Brookhaven Instruments Co. USA) at a fixed angle of 90° at room temperature. The 
morphology of the samples was studied by transmission electron microscopy (TEM, 
JEM-2010F, JEOL, Japan). ICP-MS was used to detect the contents of Gd on dot 
surface and inside the ear.  
3.2.3 Synthesis of AIE-Gd Dots 
2,3-bis(4-(phenyl(4-(1,2,2-triphenylvinyl)phenyl)amino)phenyl)furmaronitrile 
(TPETPAFN) (Figure 1a) was synthesized according to literatures.22 To fabricate AIE 
dots with amino group as the surface, a THF solution (1 mL) containing TPETPAFN 
(1 mg) and DSPE-PEG2000-NH2 (2 mg) was poured into water (10 mL) under sonication 
using a microtip probe sonicator at 12 W output (XL2000, Misonix Incorporated, NY). 
The mixture was further placed in dark in fume hood for THF evaporation at 600 rpm 
overnight. The AIE dots were further mixed and reacted with excess DOTA-NHS-ester 
overnight. After reaction, the dot suspension was dialysed against MilliQ water using 
membrane with cut-off of 6-8 kDa for 2 days to eliminate the unreacted DOTA-NHS-
ester. The obtained AIE dot suspension is further chelated with Gadolinium(III) 
chloride hexahydrate. After overnight reaction, the resultant AIE-Gd dot suspension 
was dialysed against MilliQ water using membrane with cut-off of 6-8 kDa for 2 days 
to eliminate the unreacted Gd. AIE-Gd dot suspension was further purified by filtering 
through a 0.2 µm syringe driven filter and stored at 4 °C. The obtained AIE dots were 
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further freeze-dried, and the weight of the final powder is weighted. The powder was 
dissolved in THF solution, and the absorbance of TPETPAFN is measured. According 
to the standard calibriation curve of the absorbance and concentration of TPETPAFN, 
the weight of TPETPAFN in the powder was obtained, and so as the encapsulation 
efficiency. 
3.2.4 Single Particle Fluorescence Imaging 
Fluorescence imaging of individual AIE-Gd dot was performed with a custom-
built Wide-Field Microscope (WFM) based on a Nikon ECLIPSE Ti-U inverted 
microscope frame. Light from a CW multi-line Ar ion laser (Melles Griot, CA, USA) 
was ﬁber-coupled to a Nikon TIRF attachment and focused on the back aperture of a 
high NA objective (Nikon TIRF Apo 100×, NA = 1.49, oil immersion). Immersion oil 
(nD = 1.4790, Cargille, USA) was added between the high NA objective and the cover 
slip for index matching. The luminescence was collected by the same objective. After 
passing through the dichroic mirror and the emission filter, the luminescence was 
directed onto an iXonEM+897 EMCCD camera (512 × 512 pixels, 150 nm per pixel 
resolution, Andor Technology, Northern Ireland) connected to the side port of the 
microscope. A filter set consisting of a z488/10× excitation filter, Z488RDC dichroic 
mirror, and HQ500LP emission filter was used for imaging. The camera was connected 
to a computer furbished with camera-dedicated software to control the imaging 
parameters, and for data acquisition. The samples were prepared by depositing a droplet 
of NP solutions on a glass cover slide, waiting for 30s for particles adsorption to the 
substrate, removing excess of liquid and drying under N2. Fluorescence intensity time-
traces were obtained by acquiring 1000 consecutive frames at a rate of 10 frames per 
second (100 ms exposure time, 100 s time-traces) and extracting the number of counts 
per particle at each frame. The images were analysed using Andor Solis (ver. 
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4.14.30001.0, Andor Technology, Northern Ireland) and NIS Elements Ar 4.10.00 
(Nikon, Japan) software. The fluorescence intensity time-traces were analyzed by 
subtracting the background and integrating all the remaining photon counts using a 
customized analysis software written in LabView (National Instruments). 
3.2.5 Two-Photon Absorption Measurement 
The two-photon absorption (TPA) spectrum was measured using two-photon 
induced fluorescence (TPIF) spectroscopy. The Rhodamine 6G and AIE dot solution 
were degassed before measurements. The samples were excited with laser pulses of 100 
fs produced by the mode-locked Ti:Sapphire laser (Spectraphysics Tsunami) with a 
repetition rate of 82 MHz, and a femtosecond optical parametric amplifier (OPA) was 
used within the spectral range of 800-960 nm. The emission for the AIE dot aqueous 
suspensions were collected at a 90o angle by a high numerical aperture lens and directed 
to a spectrometer’s entrance slit. Rhodamine 6G in methanol was used as the reference. 
TPA cross-sections (δ) were calculated from the following equation:[2] 
 
where δ1 and δ2 are the TPA cross-sections, F1 and F2 are the TPFI intensities, η1 and 
η2 are the fluorescence quantum yields, c1 and c2 are the concentrations, n1 and n2 are 
the refractive indexes of solvents (1 corresponds to Rhodamine 6G, 2 is AIE dot). The 
concentration of AIE dot suspension is calculated on the basis of dot as described in the 
previous chapter. 
3.2.6 Blood Vascular Imaging 
The right ears of the mice were pre-treated with 40 ul of 1% croton oil (C6719, 














severities. Control contralateral left ears were treated with only 40 ul of vehicle 
(acetone). Just before imaging, mice were anesthetized with 8 µL/g mouse bodyweight 
of 150 mg/kg ketamine and 10 mg/kg xylazine. Hair was thoroughly removed using 
Veet hair removal cream (Reckitt Benckiser), before placing the ear on a custom built 
heating platform that maintained the temperature of the mouse ear at 35 °C. Mice were 
placed on a heating pad to maintain a core body temperature of 37 °C throughout each 
imaging procedure. AIE-Gd dots (4 µL/g mouse bodyweight) at the concentration of 
100 nM based on dot concentration were administered intravenously via retro-orbital 
injection prior to imaging. All procedures were performed under the institution’s 
IACUC (Institutional Animal Care and Use Committee) guidelines. A TriM Scope II 
single-beam two-photon microscope (LaVision BioTec) with a tuneable 680-1080 nm 
laser was used to acquire the images.  
3.2.7 Evans blue Detection 
AIE-Gd dots (4 µL/g mouse bodyweight at 100 nM) and Evans blue (4 µL/g 
mouse bodyweight of 20 mg/ml) were mixed together and co-injected, immediately 
before croton oil treatment. After the pre-designated time (1, 3, 5, 7 h), the mice were 
sacrificed by carbon dioxide asphyxiation, and blood was flushed by perfusing 10 ml 
of PBS via the right ventricle of the mouse heart, while the vena cava was cut. The 
mouse ears were collected using a 2 cm by 0.7 cm stencil to ensure consistent sizes of 
samples retrieved. Evans blue dye was then extracted from the ears by N,N-
dimethylformamide (DMF) (D4451, Sigma) and the content of Evans blue in each ear 
was determined by measuring the absorbance at 620 nm. 
3.2.8 Gd Contents Detection 
After extraction of Evan blue, the obtained ears from mouse were collected and 
nitrified by the nitric acid (70%) under heating. After the ears were completely 
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decomposed, the samples were dissolved in 5% nitric acid for ICP-MS analysis. The 
contents of Gd remaining in the mouse ears were then quantitatively determined by the 
standard curve. 
3.3 Results and Discussion 
3.3.1 Fabrication of AIE-Gd Dots 
 
Scheme 3.1. Chemical structures of DSPE-PEG2000-NH2, TPETPAFN and DOTA, and the 
schematic illustration of AIE-Gd dots formation.  
2,3-Bis(4-(phenyl(4-(1,2,2-triphenylvinyl)phenyl)amino)phenyl)furmaronitrile 
(TPETPAFN) (Scheme 3.1) was synthesized according to literatures.115 The AIE dots 
were fabricated via a modified nano-precipitation methods with the assistance of 
ultrasound sonication.  An amphiphilic block copolymer, 1,2-distearoyl-sn-glycero-3-












was used as the matrix to load TPETPAFN molecules to form AIE dots. The detailed 
procedures were described in previous chapter. Upon AIE dots formation, the 
hydrophobic DSPE segments of the matrix will intertwine with TPETPAFN molecules 
to form the core, while amine group terminated polyethylene glycol (PEG) chain render 
outside towards water phase, rendering AIE dots with surface amino group for further 
functionalization with gadolinium (Gd3+). After obtain the AIE dots, 2,2',2''-(10-(2-
((2,5-dioxopyrrolidin-1-yl)oxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-
triyl)triacetic acid (DOTA-NHS ester) was  conjugated to AIE dot surface. Gd3+ was 
then chelated to AIE dot surface through DOTA moiety to render AIE-Gd dots with 
dual modal functionality. 
3.3.2 Characterization of AIE-Gd Dots 
The encapsulated TPEPTAFN is calculated to be ~31.7 wt%, equivalent to 
~4400 TPETPAFN molecules per dots. Such a high AIE fluorogen density ensures the 
high brightness of the AIE dots. Ion coupled plasma-mass spectrometry (ICP-MS) was 
used to quantify the Gd3+ content in the finally obtained AIE-Gd dots. The result 
revealed the AIE-Gd dots contain 2.3 wt% of Gd3+, which is estimated to be equivalent 
to 2100 Gd3+ ions per AIE-Gd dots. Laser light scattering (LLS) was further applied to 
access the size distribution of AIE-Gd dots, which revealed that the AIE-Gd dots have 
an average hydrodynamic size 38.9 ±  2.6 nm with narrow size distribution and a 
polydispersity of ~0.109 (Figure 3.1A). High-resolution transmission electron 
microscopy (HR-TEM) shows the morphologies of the AIE-Gd dots, which are in 




Figure 3.1. A) LLS result, and B) TEM image of AIE-Gd dots. C) Absorption and PL spectra 
of AIE-Gd dots before and after Gd chelation. D) Hydrodynamic size and fluorescence changes 
of AIE-Gd dots in 1× PBS buffer. 
The AIE-Gd dots in water suspension showed absorption and emission peaks 
centred at 512 and 670 nm, respectively, with a high quantum yield (η) of 24% 
measured with 4-(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran 
in methanol as the standard (Figure 3.1C). It should be noted that Gd3+ chelation showed 
negligible effects on the optical properties as the absorption and emission spectra of the 
AIE dots are hardly affected by chelation process, indicating high stability of the dots 
towards surface functionalization. Moreover, the size and fluorescence of the AIE-Gd 
dots remain almost unchanged after 7 days incubation in 1× phosphate-buffered saline 
(PBS) buffer (Figure 3.1D), further indicating the high colloidal stability of AIE-Gd 
dots in biological buffer. Such a high colloidal stability should be contributed by the 
existence of PEG chains, which suppress the nonspecific interaction between these 































































































AIE-Gd dots as well as the interaction between AIE-Gd dots and surrounding 
biomolecules, making them promising for the in vivo vascular imaging.  
 
Figure 3.2. A) Luminescence image, B) luminescence intensity histogram, C) representative 
luminescence intensity time-traces of TPETPAFN loaded AIE dots. 
The brightness and photostability of AIE dots were further studied by the single 
particle fluorescence imaging experiment using wide-field fluorescence microscope. 
The wide-filed fluorescence image of these individual AIE dots was shown in Figure 
3.2A, which showed very bright and uniformly distributed fluorescence. The 
corresponding histograms of total number of photons emitted by these 1216 
representative AIE dots within 100s show an average emitted photon number of 1.18 
× 106 counts (Figure 3.2B), which is much higher than selected benchmark (QD655, 
2.8 × 105 counts), indicating the high brightness of the AIE dots. Continuous laser 
irradiation was used to study the photostability of AIE dots. The real-time fluorescence 
















































intensity of four individual AIE dots were collected by the integration of the emission 
of these dots over 100 ms for 1000 consecutive frame. The results are shown in Figure 
3.2C, where negligible effects to the fluorescence intensity of 4 representative AIE dots 
was observed under the continuous laser scanning, indicating high resistance of AIE 
dots towards photobleaching. In addition, no blinking or intermittency was observed 
for all AIE dots (Figure 3.2C), such a stable fluorescence further make them a 
promising candidate for real-time single dot tracing, as well as red blood cells (RBCs) 
flow measurement and other applications. 
 
Figure 3.3. Two-photon absorption spectrum of AIE dots in water. 
Materials with high TPA cross section are able to emit strong visible 
fluorescence from low-energy irradiation in the NIR region, which minimizes the 
absorbance of biosubstrate, and is beneficial for clear intravital imaging at high 
resolution levels. The TPA spectrum of AIE-Gd dots in aqueous solution was measured 
using a TPFI microscope with a tunable Ti:sapphire laser, using Rhodamine 6G in 
methanol as the standard. As a comparison, Evans blue, a commonly used blood 
vascular imaging contrast and inflammation detection probe, is also selected for the 
TPA measurement. The emission signals of AIE-Gd dots and Evans blue were collected 



































upon excitation from 800 to 920 nm, and their corresponding TPA spectra were shown 
in Figure 3.3. As shown, the maximum TPA cross section (δ) value of AIE-Gd dots is 
measured to be 6.7 × 104 GM (based on dots concentration) upon excitation at 810 nm, 
which is much higher than that of Evans blue.  Such a high TPA cross section of AIE-
Gd dots in aqueous media is highly desirable for high resolution intravital imaging. 
3.3.3 Inflammation Imaging 
 
Figure 3.4. Intravital TPFI of mouse ears A) without or B) with inflammation. The 
inflammatory ear was first treated with 1% croton oil (40 µL) for 3 h, followed by AIE-Tat dots 
injection, and immediate imaging.  
Real-time two-photon inflammation detection and imaging in transgenic live 
mice with AIE-Gd dots is investigated using an intravital two-photon microscope. The 
neutrophils of the mice are green fluorescent protein (GFP) gene modified to provide 
green fluorescence. Croton oil that can cause irritation and swelling was used to induce 
mouse ear inflammation. After treatment the left ear with 40 µL of croton oil for 3 h, 
AIE-Gd dots (100 nM, 40 µL/gram of mouse weight) were administered intravenously 
prior to two-photon fluorescence imaging. Figure 3.4 shows the images of ear blood 
vessels of healthy ear, and inflammation ear, respectively. As shown, the major blood 
vessels as well as the smaller capillaries in the pia meter could be clearly visualized by 





surfaces, nonspecific binding is blocked, the AIE dots showed excellent colloidal 
stability in blood vessels, and therefore, smooth flow and negligible large AIE dots 
aggregates in health blood vascular were observed. Moreover, neither obvious leakage 
of AIE-Gd dots from blood vessels nor increase of background signal could be observed 
within tested period (over 30 min), revealing the excellent vascular retention ability of 
AIE-Gd dots, which outperforms Evans blue, which showed significant leakage even 
in moral healthy blood vessels. On the contrary, two-photon fluorescence image of 
croton oil treated inflammatory ear is quite different. As observed in Figure 3.4B, lots 
of red fluorescence outside vascular was observed. These AIE-Gd dots not only tend to 
leak out from the blood vessel and diffuse into surround tissue, but also are able to bind 
the outer layer of the blood vessels in the inflammatory ear. The accumulation of green 
fluorescence neutrophils in the inflammation ear was also observed, which further 
indicates that our AIE-Gd dots have the capability to detect and image the vascular 
leakage induced by inflammation.  
In a parallel experiment, we performed the croton oil treatment and the 
intravenously injection of AIE-Gd dots (40 µL/gram of mouse weight) at the same time. 
And the two-photon fluorescence imaging was conducted at 3 h post-injection. The 
results are shown in Figure 3.5. As shown, almost no red fluorescence from blood 
vascular can be observed for healthy ear under the same imaging condition. The result 
clearly indicates the excellent clearance of our AIE dots, as very weak red fluorescence 
in observed in blood vascular at 3-h post-injection. The absence of red fluorescence in 
the healthy ear also revealed that our AIE dots will not leak outside from the blood 
vascular, providing extremely low background signal. On the other hand, as for the 
inflammatory ear, bright red fluorescence was observed from the inside and outside of 
blood vascular, providing a clear visualization of inflammations. The excellent 
 74 
 
inflammation imaging and quick clearance make our AIE dots an ideal candidate for 
inflammation imaging in practical applications. 
 
Figure 3.5. Intravital TPFI of mouse ears A) without or B) with inflammation. The croton oil 
treatment and AIE dots injection were conducted as the same time. At 3 h post-injection, croton 
oil is removed, and the images were obtained.  
 
3.3.4 Quantification of Vascular Leakage 
 
Figure 3.6. A) Amount of Gd and B) absorption of Evans blue in inflammation and healthy 
ears after designated croton oil treatment. The AIE-Gd dots and Evans blue was injected at the 
starting time of croton oil treatment. 
We subsequently utilized the contents of Gd3+ remaining in the ear to 
quantitatively determine the severity of inflammation, using Evans blue as the 
benchmark. The croton oil treatment, and the injection of AIE-Gd dots and Evans blue 
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were conducted simultaneously.  The mice were sacrificed at 1, 3, 5 and 7 h post-
injection. The blood was flashed and the ears were cut for analysis. N,N-
dimethylformamide (DMF) was used to extract Evans blue from the ear, and the amount 
of remaining Evans blue in the ear was evaluated by measuring its absorption at 620 
nm. The ears were further nitrified, the amount of residue Gd3+ was accessed by ICP-
MS. As shown in Figure 3.6A, Gd3+ content in the 1 h croton oil treated inflammatory 
ear is ~4.8-fold of that in the healthy ear of the same mouse, while Evans blue only 
showed less than 2-fold increase (Figure 3.6B). Moreover, upon increase the 
inflammation severity to 7 h croton oil treatment, the Gd3+ content difference between 
inflammation ear and healthy ear increases to over 8 fold, while the Evans blue 
difference is less than 3-fold. These results clearly indicate that our AIE-Gd dots have 
higher sensitivity than traditional measurement of Evans blue absorption method for 
inflammation detection. In addition, upon increasing the croton oil treatment, the Gd3+ 
content in the healthy ear remains almost the same, while Evans blue showed gradually 
increased absorbance, indicating that our dots have better vascular retention than Evans 
blue, which helps to provide a higher sensitivity and lower background signal, and a 
clear and direct visualization of inflammation. 
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3.3.5 Real-Time Monitoring of Vascular Leakage 
 
Figure 3.7. A) Time-lapse images of AIE-Gd dots treated mouse ear before and after laser burn. 
B) Fluorescence intensity changes of selected two areas before and after laser burn. The 
neutrophils are GFP genetically modified.  
To real time monitoring the leakage of AIE-Gd dots upon inflammation or 
injury, the mouse was intravenously injected with our dots, followed by blood vascular 
imaging. In the duration of imaging, the selected area is burned by an intense laser 
beads, and the leakage of AIE-Gd dots was monitoring by the TPFI microscope. As 
shown in the Figure 3.7A, upon laser burning, a quick accumulation of red fluorescence 
in the burnt area is observed, which is even faster than the accumulation of neutrophils. 
We also monitored the fluorescence changes during the injury imaging. As shown, the 
fluorescence in the burnt areas quick increased over 20-fold within 10 min, while the 
blood vessel away from it showed unchanged fluorescence intensity. The results further 
reinforced that our AIE-Gd dots could be utilized for facile real time inflammation or 
injury detection and imaging. 
 




























In conclusion, this chapter presented a general approach to introduce more 
functional materials or modalities to AIE dots, and demonstrated their in vivo 
applications for detection and imaging of blood vascular integrity and leakage. 
Benefiting from the high brightness of AIEgens in aggregates, organic AIE dots with 
strong red emission and photostability under two-photon excitation were successfully 
fabricated. Gadolinium was further chelated onto the AIE dots surface to yield AIE-Gd 
dots with dual modalities. The Gd chelation did not affect the optical properties of AIE 
dots, and they exhibit excellent stability in biological environment. Upon intravenously 
injection into mouse, the blood vascular will be light up, clearly and distinguishable red 
fluorescence with weak background signal from outside blood vessel can be observed 
under two-photon excitation. Under inflammation, the vascular permeability will 
increase, and our AIE dots will leak outside from the blood vascular, serving as an in 
vivo fluorescence marker for blood vascular integrity and leakage. Moreover, the Gd 
contents chelated onto the AIE dots can also provide the quantitatively analysis of the 







CHAPTER 4  
ORGANIC DOTS WITH AGGREGATION-INDUCED 
EMISSION CHARACTERISTICS FOR TARGETED AND 





Image-guided therapy that combines the diagnostic and therapeutic effects into 
one delivery system has shown its own advantage and attracted great attentions in 
biological researches and practical applications.137, 138 Among these developed image-
guided therapy systems, photodynamic therapy (PDT) that utilizes a beam of light, 
oxygen, and photosensitizers (PSs) to produce reactive oxygen species (ROS) that are 
toxic to tumor has been served as an elegant approach for cancer therapy.139  The 
therapeutic effects of PDT can be readily and precisely controlled by the location of the 
light beam with high spatiotemporal precision and noninvasive properties.140, 141 In 
addition, these PSs are also able to emit fluorescence under light illumination, providing 
the chance for visualization of the tumor location and the therapeutic effects.142 
However, as conventional fluorogens, most PSs, such as the widely used porphyrin 
derivatives are readily to aggregate due to their large hydrophobicity and the rigid 
planar chemical structures. This π–π stacking in aggregate states always resulted in 
quenched fluorescence and reduced ROS generation.143, 144 When being encapsulated 
or loaded into nanoparticles (NPs), this quenching and reduction phenomena are even 
more severe, largely compromising their PDT performance.86 Many effects have been 
put on to fight against this,145-147  but this natural process of aggregation for fluorogens 
and PSs is inevitable, and hence it holds great potentials to design new class of PSs 
showing efficient ROS generation in aggregate states. 
We have demonstrated that the fluorogens with aggregation-induced emission 
characteristics (AIEgens) are able to emit strong fluorescence in aggregates or be 
encapsulated into nanoparticles.74, 148, 149 Such unique and exciting properties of 
AIEgens make it possible for design of AIE light-up probes and AIE dots for biological 
sensing and imaging.150-155 In addition, several AIEgens have been applied in PDT, but 
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they only served as energy donor to enhance the ROS generation of porphyrin 
derivatives.55, 156, 157 And there has been no report on AIEgens that inherently possess 
the ROS generation capability. 
In this chapter, for the first time, we demonstrated that AIEgens can not only show 
bright fluorescence but also be able to efficiently generate ROS in aggregates. Such 
properties make them the ideal candidates for image-guided PDT. Using 2-(2,6-bis((E)-
4-(phenyl(4′-(1,2,2-triphenylvinyl)-[1,1′-biphenyl]-4-yl)amino)styryl)-4H-pyran-4-
ylidene)malononitrile (TPETPADCM) as an example, we fabricated the organic AIE 
dots using 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[maleimide(polyethylene glycol)] (DSPE-PEG2000-Mal)  as encapsulation matrix. The 
resultant AIE dots is further conjugated with cyclic arginine-glycine-aspartic acid 
(cRGD) peptide, which can selectively target the cancer cells with integrin overexpress 
for targeted and image-guided PDT. The TPETPADCM-cRGD dots can generate ROS 
very efficiently under appropriate light irradiation, which showed selective cellular 
uptake and toxicity to targeted MDA-MB-231 cells upon light irradiation while keeping 
control cells intact. 
 
4.2 Experimental  
4.2.1 Materials 
  1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-
[maleimide(polyethylene glycol)-2000] (DSPE-PEG2000-Mal) was purchased from 
Avanti Polar Lipids, Inc.  3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) and other unmentioned chemicals were all purchased from Sigma-
Aldrich and used as received without further purification. Thiolated cyclic (Arg-Gly-
Asp-D-Phe-Lys(mpa)) peptide (c(RGDfK)) was customized from GL Biochem Ltd 
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(Shanghai). Dulbecco’s Modified Essential Medium (DMEM) is a commercial product 
of National University Medical Institutes (Singapore). Milli-Q water was supplied by 
Milli-Q Plus System (Millipore Corporation, Breford, USA). 10× phosphate-buffer 
saline (PBS) buffer with pH = 7.4 (ultrapure grade) is a commercial product of 1st 
BASE (Singapore). Milli-Q water (18.2 MΩ ) was used to prepare the buffer solutions 
from the 10× PBS stock buffer. 1× PBS contains NaCl (137 mM), KCl (2.7 mM), 
Na2HPO4 (10 mM), and KH2PO4 (1.8 mM). Fetal bovine serum (FBS) and trypsin-
EDTA solution were purchased from Gibco (Life Technologies, AG, Switzerland). 
Annexin V-FITC apoptosis detection kit was also purchased from Life Technologies. 
4.2.2 Characterization 
Particle size and size distribution were determined by laser light scattering (LLS) 
with a particle size analyzer (90 Plus, Brookhaven Instruments Co., USA) at a fixed 
angle of 90° at room temperature. TEM images were obtained from a JEOL JEM-2010 
transmission electron microscope with an accelerating voltage of 200 kV. UV-vis 
absorption spectra were taken on a Milton Ray Spectronic 3000 array 
spectrophotometer. Photoluminescence (PL) spectra were measured on a Perkin-Elmer 
LS 55 spectrofluorometer. All UV and PL spectra were collected with quarz cuvette at 
24 ± 1 °C. 
4.2.3 Preparation of AIE Aggregates 
2-(2,6-Bis((E)-4-(phenyl(4′-(1,2,2-triphenylvinyl)-[1,1′-biphenyl]-4-
yl)amino)styryl)-4H-pyran-4-ylidene)malononitrile (TPETPADCM) was synthesized 
according to previous reports. AIEgens were firstly dissolved in THF to make the stock 
solution at a concentration of 0.1 mM. To form the AIE aggregates, 1 mL of THF stock 
solution were added into 10 mL MilliQ water under string at 600 rpm. After THF 
evaporation, the aggregates were obtained at concentration of 0.01 mM. 
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4.2.4 ROS Measurement in Solution 
Dichlorofluorescin (DCFH) was used as the indicator for ROS generation 
measurement in solution. To prepare DCFH, 0.5 mL of 1 mM 2’-7’ dichlorofluorescin 
diacetate (DCFH-DA, signal) in ethanol solution is added into 2 mL of 0.01 NaOH 
solution. And the mixture is placed at room temperature for 30 min. The hydrolysate is 
further neutralized with 10 mL of 25 mM PBS buffer. The DCFH is stored on ice in 
dark before use. To measure ROS generation, DCFH is added into the solution of AIE 
aggregates to obtain a working concentration of 40 µM. the mixture is exposed to light 
irradiation for different time, and the emission spectra of the mixture is obtain upon 
excitation at 460 nm. The enhancement fold of the DCFH fluorescence intensity at 530 
nm is used to quantify the ROS generation efficiency. 1,3-diphenylisobenzofuran 
(DPBF) that quickly reacts with ROS with reduced absorbance was also used for 
measuring the ROS generation of AIE dots. 
4.2.5 Preparation of TPETPADCM Loaded AIE Dots  
DSPE-PEG2000-Mal (2 mg) and TPETPADCM (1mg) were fully dissolved in 1 
mL THF solution, which was then poured into water (10 mL). This was followed by 
sonicating the mixture for 2 minutes at 12 W output using a microtip probe sonicator 
(XL2000, Misonix Incorporated, NY). The mixture was then stirred at room 
temperature overnight to evaporate the organic solvent. The NP suspension was further 
filtered with a 0.2 µm syringe filter to obtain TPETPADCM AIE dots. 
4.2.6 Conjugation of cRGD to TPETPADCM Dots  
Thiolated cRGD was conjugated to the surface of TPETPADCM dots (denoted 
as TPETPADCM-cRGD dots) as the following procedure. The TPETPADCM dots 
were suspended in HEPES buffer (0.2 mg mL-1) and incubated with excess thiolated 
cRGD at room temperature for 6 h. Then the cRGD functionalized nanoparticles were 
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washed with Milli-Q water (3 mL × 3 times) by ultrafiltration (20,000 MWCO, Amicon, 
Millipore Corporation, Bedford, USA), suspended in Milli-Q water and stored at 4 °C 
for further use. 
4.2.7 Cell Culture  
The breast cancer cell line MDA-MB-231, MCF-7 and normal cell line NIH 
3T3 were provided by American Type Culture Collection (ATCC). The cells were 
cultured in DMEM (Invitrogen, Carlsbad, CA) containing 10% heat-inactivated FBS 
(Invitrogen), 100 U mL-1 penicillin, and 100 μg mL-1 streptomycin (Thermo Scientific) 
and maintained in a humidified incubator at 37 °C with 5% CO2. Before experiment, 
the cells were precultured until confluence was reached. 
4.2.8 Intracellular ROS Detection  
ROS generation inside cells under light irradiation was detected using 
dichlorofluorescein diacetate (DCF-DA) cellular reactive oxygen species assay kit 
(Abcam). MDA-MB-231, MCF-7 and NIH 3T3 cells were cultured in the chambers 
(LAB-TEK, Chambered Coverglass System) at 37 °C. After 80% confluence, the 
culture medium was removed and washed twice with PBS buffer. Following incubation 
with TPETPADCM-cRGD dots (10 μg mL-1) for 1 h in the dark, DCF-DA was loaded 
into the cells. After 10 min incubation, cells were washed twice with PBS and then 
exposed to light irradiation for 10 s at the power density of 0.25 W cm-2. After 
irradiation, the medium was replaced with PBS and fluorescence images of treated cells 
were acquired using a laser confocal microscope. 
4.2.9 Confocal Imaging  
MDA-MB-231, MCF-7 and NIH 3T3 cells were cultured in the chambers at 
37 °C. After 80% confluence, the culture medium was removed and washed twice with 
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PBS buffer. Following incubation with TPETPADCM-cRGD dots (10 μg mL-1) for 1 
h, the cell nucleus were living stained with Hoechst 33342 (Life Technologies), 
following the standard protocol of the manufacturer. The cellular apoptosis imaging 
measurement was carried out based on standard detection kit (Annexin V-FITC 
Apoptosis Detection Kit) according to manufacturer’s protocol. The cells were then 
imaged immediately by confocal laser scanning microscope (CLSM, Zeiss LSM 410, 
Jena, Germany). The images were analysed by Image J 1.43 × program (developed by 
NIH, http://rsbweb.nih.gov/ij/). 
4.2.10 Cytotoxicity Studies 
 3-(4,5-Dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays 
were used to assess the metabolic activity of MDA-MB-231, MCF-7 and NIH 3T3 cells. 
The cells were seeded in 96-well plates (Costar, IL, USA) at an intensity of 4 × 104 
cells mL-1. After 24 h incubation, the medium was replaced with the TPETPADCM-
cRGD dots at different concentrations and incubated at 37 °C. Following incubation 
with TPETPADCM-cRGD dots for 1 h, cells were washed twice with PBS and then 
exposed to light irradiation for 2 min at the power density of 0.25 W cm-2. The cells 
were further incubated for 24 h and then washed twice with 1× PBS buffer, and 100 μL 
of freshly prepared MTT (0.5 mg mL-1) solution in culture medium was added into each 
well. The MTT medium solution was carefully removed after 3 h incubation in the 
incubator at 37 °C. DMSO (100 μL) was then added into each well and the plate was 
gently shaken to dissolve all the precipitates formed. The absorbance of MTT at 570 
nm was monitored by the microplate reader (Genios Tecan). Cell viability was 
expressed by the ratio of absorbance of the cells incubated with TPETPADCM-cRGD 
dots to that of the cells incubated with culture medium only. The relative cell survival 
percentages compared to the dots-free control were plotted against the drug 
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concentration in logarithmic scale. The data reported represent an average of three 
measurements from different batches. The dose-effect profiles were obtained by 
sigmoidal logistic fitting by use of Origin 8.0 (OriginLab, Northampton, MA) and the 
half-maximal inhibitory concentration (IC50) values were determined on the basis of the 
fitted data. 
4.3 Results and Discussion 
4.3.1 Synthesis and Characterization of TPETPADCM 
 
Figure 4.1. A) Chemical structure of TPETPADCM. B) PL spectra of TPETPADCM (λex = 
502 nm) in THF/water mixtures with different water fractions (fw). 
We synthesized TPETPADCM according to our previous report, and the 
structure is shown in Figure 4.1A.74 The AIE characteristics of TPETPADCM was 
firstly study by measuring its photoluminescence (PL) spectra in THF and water 
mixtures with different water fractions (fw) (Figure 4.1B). In pure THF solution, 
TPETPADCM shows moderate fluorescence. Upon gradual increase fw (from 0 to 40%), 


















































the emission of TPETPADCM is dramatically weakened and the emission color is 
bathochromically shifted, due to the increase in the solvent polarity and the 
transformation to the twisted intramolecular charge transfer (TICT) state. Upon further 
increasing fw over 40 vol %, the light emission of TPETPADCM is invigorated and is 
intensified with a further increase in fw, indicating that TPETPADCM is an AIE active 
luminogen.74, 149  
 
Figure 4.2. A) PL spectra of the mixture of TPETPADCM aggregates and DCFH. B) DCFH 
PL peak intensity changes under continuous light irradiation.  
To demonstrate the ROS generation capability of TPETPADCM in aggregates, 
we used dichlorofluorescin (DCFH) as the indicator. DCFH can readily react with ROS 
to result in increased emission at 530 nm. As shown in Figure 4.2A, exposure the 
mixture of TPEPTADCM aggreagtes and DCFH to whit light irradiation, the emission 
of DCFH at 530 nm will quickly increase. The fluorescence intensity enhancement of 
DCFH is over 200-fold (Figure 4.2B). In addition, only exposure DCFH itself to light 
irradiation, almost on change of its fluorescence intensity is observed, excluding the 
possibility of DCFH as the PSs. These results clearly demonstrated that TPETPADCM 
can efficiently generate ROS in the aggregated state. 
 






























































4.3.2 Synthesis and Characterization of TPETPADCM-cRGD Dots 
 
Scheme 4.1. Schematic illustration of TPETPADCM-cRGD dots for image-guided 
photodynamic therapy. 
The TPETPADCM dots were prepared using DSPE-PEG2000-Mal as the 
encapsulation matrix following the nano-precipitation method as described in the 
previous chapters. Upon transferring them from THF to water phase, the hydrophobic 
DSPE segment will intertwine TPETPADCM to form the core, while hydrophilic PEG 
chains will render outside towards water phase and provide the surface maleimide 
group for further conjugation. The targeting moiety towards cancer cells with 
overexpressed αvβ3 integrin, cRGD-SH, was then conjugated to the TPETPADCM dot 
surface through click chemistry between the surface maleimide and -SH to yield the 


















Figure 4.3. A) Size distribution and TEM image (inset), B) absorption and emission spectra, 
and C) ROS generation of TPETPADCM-cRGD dots. 
Laser light scattering (LLS) results revealed the hydrodynamic size distribution 
of TPETPADCM-cRGD dots, which has an average size of ~32 nm with a low 
polydispersity of ~0.12 (Figure 4.3A). Transmission electron microscopy (TEM) image 
showed that TPETPADCM-cRGD dots are spherical nanoparticels with a mean size of 
~30 nm. The UV-Vis and photoluminescence (PL) spectra of T-TTD NPs are shown in 
Figure 4.3B. They have two absorption peaks centred at 353 and 502 nm, respectively, 
with an emission maximum peaked at 669 nm. The fluorescence quantum yield was 
101%, measured using Rhodamine 6G in methanol as the standard. The corresponding 
ROS generation capability of TPETPADCM-cRGD dots was then evaluated using 1,3-













































































diphenylisobenzofuran (DPBF) as the indicator, which could quickly react with ROS 
with reduced absorbance. As shown in Figure 4.3C, upon exposure to light irradiation, 
the solution shows quickly decreased absorbance at 418 nm (16.3% of its original after 
1 min irradiation), which is indicative of efficient ROS generation by TPETPADCM-
cRGD dots. Possessing the high brightness and ROS generation under illumination, the 
TPETPADCM-cRGD dots should be able to selectively recognize αvβ3 integrin 
overexpressed cancer cells and kill them. 
 
4.3.3 Targeted Cellular Imaging 
To test the targeting effect of TPETPADCM-cRGD dots, MDA-MB-231 cancer 
cells with overexpressed αvβ3 integrin on cellular membrane were chosen as integrin-
positive cancer cells, while MCF-7 cancer cells and NIH 3T3 normal cells with low 
αvβ3 integrin expression were used as the negative controls. We incubated the 
TPETPADCM-cRGD dots with MDA-MB-231, MCF-7 and NIH 3T3 cells for 1 h. The 
confocal images are shown in Figures 4.4, where strong red fluorescence of 
TPETPADCM-cRGD dots in the cytoplasm and blue fluorescence of Hoechst from cell 
nucleus are simultaneously observed in MDA-MB-231 cells (Figure 4.4A). It is 
obvious that the red fluorescent signals in MCF-7 (Figure 4.4B) and NIH 3T3 (Figure 
4.4C) cells are much weaker than that in MDA-MB-231 cells, indicating the 
TPETPADCM-cRGD dots are able to recognize and selectively image of MDA-MB-
231 cells with αvβ3 integrin overexpression. Receptor blocking experiments were also 
carried out to investigate the uptake mechanism of TPETPADCM-cRGD dots. In these 
experiments, free cRGD was first incubated with MDA-MB-231 cells before 
TPETPADCM-cRGD dot were added. As shown in Figure 4.4D, the red fluorescent 
signal of T-TTD NPs is dramatically reduced when the integrin is initially blocked with 
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the excess cRGD. These results demonstrated that the TPETPADCM-cRGD dots were 
uptaken through αvβ3 integrin receptor-mediated endocytosis. 
 
Figure 4.4. Confocal images of A) MDA-MB-231, B) MCF-7, C) NIH 3T3 cells, and D) free 
cRGD (50 µM) pre-treated MDA-MB-231 cells upon incubation with TPETPADCM-cRGD 
dots (1 μg/mL) for 1 h. The blue fluorescence from the nuclei of cells is dyed by Hoechst 33342, 
the red fluorescence is from TPETPADCM-cRGD dots. All the images share the same bar of 
20 μm.  
To evaluate whether the TPATPADCM-cRGD dots are able to generate ROS 
inside the cells, we used a cell permeable fluorescence dye dichlorofluorescein 
diacetate (DCF-DA). DCF-DA is able to be rapidly oxidized to highly fluorescent 
dichlorofluorescein (DCF) in the presence of ROS. As shown in Figure 4.5, strong 
green fluorescence of DCF was observed inside the targeted MBA-MD-231 cells, 
demonstrating efficient ROS generation from the TPETPADCM-cRGD dots. In 






incubated with MCF-7 (Figure 2E) or NIH 3T3 (Figures 4.5B and C) cells, due to the 
poor cellular uptake of TPETPADCM-cRGD dots. 
 
Figure 4.5. Detection of intracellular ROS production by dichlorofluorescein diacetate (DCF-
DA) in A) MDA-MB-231, A) MCF-7 and C) NIH 3T3 cells after incubation with 
TPETPADCM-cRGD dots (10 μg/mL) followed by light irradiation. All the images share the 
same scale bar of 50 μm. 
 
4.3.4 Photodynamic Therapy 
The photodynamic therapy performance of TPETPADCM-cRGD was 
evaluated by standard methylthiazolyldiphenyltetrazolium bromide (MTT) assay. The 
viability of MDA-MB-231, MCF-7, NIH 3T3 cells after incubation with 
TPEPTADCM-cRGD dots at different concentrations was studied. As shown in Figure 
4.6A, without the light irradiation, all the cells exhibit very high viability nearly 100%, 
indicative of non-toxicity and good biocompatibility of TPETPADCM-cRGD dots in 





the TPETPADCM-cRGD dots only showed obvious cytotoxicity to MDA-MB-231 
cells. The toxicity increased with the TPETPADCM-cRGD dot concentration, with a 
half-maximal inhibitory concentration (IC50) of 11 μg mL-1 under our experimental 
conditions.  
 
Figure 4.6. Inhibition of MDA-MB-231, MCF-7 and NIH 3T3 cells growth in the presence of 
different concentrations of TPETPADCM-cRGD dots A) without or B) with light irradiation 
(0.25 W cm-1, 2 min) followed by further incubation of the cells for 24 h. Data represent mean 
values ± standard deviation, n = 3. 
Apoptosis is the process of programmed cell death, and photodynamic treated 
can induce this cell apoptosis process. We used fluorescein isothiocyanate (FITC)-
tagged Annexin V, one of the most commonly used fluorescent probes to distinguish 
viable cells from apoptotic ones, to visualize the apoptosis cells in our experiment.  
Annexin V can bind to the membrane of apoptotic cells which express 
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phosphatidylserine. As shown in Figure 4.7A, after incubation of TPETPADCM-cRGD 
dots with light irradiation in MDA-MB-231 cells, green fluorescence attributed to FITC 
is clearly observed from the cell membrane, indicating that the cells possibly underwent 
apoptosis process. No FITC signal is detectable in MCF-7 (Figure 4.7B) and NIH 3T3 
(Figure 4.7C) cells, which agrees with the results shown in Figures 4.4-6. The overall 
results indicate that the cRGD moiety is able to guide the TPETPADCM-cRGD dots to 
αvβ3 integrin overexpressed tumor cells, resulting in selective cancer cell killing due to 
the ROS generation. 
 
Figure 4.7. Cell apoptosis imaging using FITC-tagged Annexin V in MDA-MB-231 (A), MCF-
7 (B) and NIH 3T3 (C) cells incubated with TPETPADCM-cRGD dots after light irradiation. 








In summary, in chapter, we demonstrated that AIEgen can also act as PSs, 
moreover, they are able to show efficient ROS generation in aggregated state. We 
fabricated AIE dots based on a red-emissive fluorogen with AIE characteristics as the 
PS for imaging-guided PDT. To selectively target a specific type of cancer cells, cRGD 
peptide was conjugated to the NP surface. Due to the suppressed nonspecific cellular 
uptake, the fabricated TPETPADCM-CRGD dots showed targeted cellular imaging 
towards αvβ3 integrin overexpressed cancer cells with high sensitivity and selectivity. 
Cell viability studies showed that TPETPADCM-cRGD dots could selectively and 
efficiently kill the targeted cancer cells under a beam of light irradiation. This PDT 
platform based on AIEgens is simple to design and synthesis, which offers new 







CHAPTER 5  
CELLULAR AND MITOCHONDRIA DUAL TARGETED 
ORGANIC DOTS WITH AGGREGATION-INDUCED 






Mitochondria are the vital sub-cellular organelles to eukaryotic cells and 
powerhouse of cell activity.158, 159 Mitochondria medicine has emerged as a new field 
of biomedical and pharmacological research.160 To achieve the mitochondria targeting 
with enhanced therapy effects, the therapeutic reagents need to internalize into targeted 
cells and accumulate at mitochondria sites.161-163 This is much more crucial when it 
comes to photodynamic therapy (PDT) as mitochondria are the main targeted of singlet 
oxygen,164-166 and the singlet oxygen is short in lifetime (< 0.04 µs) as well as radius of 
action (< 0.02 µm).167-170 Direct modification of drugs or photosensitizers (PSs) with 
mitochondria targeting ligands has been prevalent in last decades to direct drug cargoes 
to mitochondria.167, 171-176 However, these approaches required tedious synthetic 
processes with limitations that the post-modified drugs or molecules may not be able to 
maintain their therapeutic effects.177  
Recently, nanotechnology or nanocarrier systems have been considered as a simple 
and non-chemical approach to deliver drug molecules to specific targeted cells or 
subcellular organelles of interest with enhanced stability and pharmacokinetics.177-182 
Up to now, various nanocarriers including liposome micelles or solid nanoparticles 
(NPs) have been reported to be able to deliver the loaded drugs to mitochondria.183-190 
but none of them possesses the selectivity towards different cell lines. Moreover, the 
aggregation-caused quenching (ACQ) effect of traditional PSs often leads to quenched 
fluorescence as well as reduced ROS generation when they naturally aggregated or 
accumulated in limited area,191-193 which largely compromised the efficiencies of PDT. 
Moreover, the existence of ACQ effect also makes it difficult to develop NPs with 
bright fluorescence and efficient ROS production for image-guided PDT based on 
traditional PSs. We and other have reported the novel fluorogens with aggregation-
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induced emission (AIEgen) characteristics,39, 42, 110-114 which has attracted great 
research interests in biological and biomedical applications. Very recently, we and 
others also found that several AIEgens show efficient ROS production in aggregate 
state.52, 53, 88, 194 These unique properties are ideal for mitochondria targeted PDT since 
encapsulation of AIEgens by mitochondria targeted nanocarriers will not compromise 
their fluorescence and ROS generation.  
In this chapter, we developed a facile strategy of fabrication of AIE dots with bright 
red fluorescence and high ROS generation for cellular and mitochondrial dual-targeted 
PDT, which served as the extension of previous chapter. We synthesized a new AIEgen, 
DPBA-TPE, which showed strong red fluorescence and efficient ROS generation in 
aggregates under light illumination. The corresponding AIE dots were then fabricated 
by a modified nano-precipitation method using DSPE-PEG as encapsulation matrix. 
Bearing folic acid and triphenylphosphine (TPP) targeting ligands at the surface, the 
yielded FA-AIE-TPP dots are able to selectively internalize into folate-receptor (FR) 
positive cancer cells over other cells and subsequently accumulate in mitochondria. The 
dual targeted FA-AIE-TPP dots showed enhanced PDT effects as compared to sole 
cellular targeted or mitochondria targeted AIE dots. Our NP formulation thus represents 
a simple and general strategy for cellular and subcellular dual targeted delivery.  
5.2 Experimental  
5.2.1 Materials 
1,4-Bis(bromomethyl)-2,5-dimethoxybenzene (2), 2,5-bimethoxybenzene-1,4-
dicarboxaldehyde (3), and N-(4-(1,2,2-triphenylvinyl)phenyl)benzenamine (10), were 
prepared according to the literature. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-




FA) were purchased from Avanti Polar Lipids, Inc. All the other chemicals and reagents 
were purchased from Sigma-Aldrich and used as received without further purification.  
5.2.2 Characterization 
 1H spectrum was measured on a Bruker AV 300 or 400 spectrometer in CD2Cl2 
using tetramethylsilane (TMS; δ = 0) as internal reference. High resolution mass spectra 
(HRMS) were recorded on a GCT premier CAB048 mass spectrometer operating in 
MALDI-TOF mode. The UV-vis and PL spectra were measured on UV-1700 
(Shimadzu, Japan) and LS-55 (Perkin Elmer, USA) spectrometer, respectively. Laser 
light scattering with a particle size analyzer (90 Plus, Brookhaven Instruments Co. USA) 
was used to determine the hydrodynamic diameters of AIE dots. Zeta-potential of AIE 
dots was determined by Zetasizer (Malvern, UK). High-resolution transmission 
electron microscope (HR-TEM, JEM-2010F, JEOL, Japan) was used to study the 
morphology and size of AIE dots. 
5.2.3 Preparation of DPBA-TPE 
The DPBA-TPE molecular was synthesized by Qin Wei (HKUST). A dry 
ethanol solution (30mL) of sodium hydroxide (40 mg) was added to a mixture of 4-
bromophenylacetonitrile (873 mg, 4.5 mmol) and 2,5-bimethoxybenzene-1,4-
dicarboxaldehyde (388 mg, 2 mmol) under a nitrogen atmosphere. The reaction mixture 
was stirred for 12 h at room temperature, and the precipitate was filtered out and washed 
with water and DCM. An orange powder (5) was obtained in 81.9% yield (904 mg).  
Compound 5 (200 mg, 0.364 mmol) was reacted with 10 (381 mg, 0.9 mmol) in the 
presence of Pd(OAc)2 (11.2 mg, 0.05 mmol), Cs2CO3 (487 mg, 1.5 mmol), P(t-Bu)3 
(30.3 mg, 0.15 mmol) and toluene (40 mL) at 110 °C for 24 h under a nitrogen 
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atmosphere. Water (30 mL) and chloroform (300 mL) were then added after cooling to 
room temperature. The obtained organic layer was washed with brine, dried by 
anhydrous MgSO4 and further dried under reduced pressure. Column chromatography 
on silica gel using hexane/DCM as eluent was they applied to purify the crude product. 
The afforded DPBA-TPE as a red solid in 68% yield (305 mg). 1H NMR (400 MHz, 
CD2Cl2), δ (TMS, ppm): 7.90 (s, 2H), 7.88 (s, 2H), 7.55 (d, J = 8.8 Hz, 4H),  7.30 (t, J 
= 8.0 Hz, 4H), 7.18-7.02 (m, 40H), 6.94 (d, J = 8.4 Hz, 4H), 6.85 (d, J = 8.4 Hz, 4H), 
3.94 (s, 6H). 13C NMR (75 MHz, CDCl3), δ (TMS, ppm): 152.32, 149.09, 147.25, 
145.65, 144.32, 144.14, 143.92, 141.36, 140.98, 139.70, 133.78, 132.66, 131.67, 
131.64, 131.61, 129.79, 128.19, 128.05, 128.02, 127.25, 126.86, 126.83, 126.76, 
125.94, 125.47, 124.34, 124.22, 122.76, 118.79, 111.89, 110.58, 56.74. HRMS 
(MALDI-TOF, m/z): [M+] calcd for C90H66N4O2, 1234. 5186; found, 1234.5192. Anal. 
calcd for C90H66N4O2: C, 87.49; H, 5.38; N, 4.53; O, 2.59. found: C, 87.61; H, 5.33; N, 
4.52. 
5.2.4 Preparation of DPBA-TPE Nanoaggregates  
DPBA-TPE was fully dissolved in THF to prepare the stock (100 µM). 
Appropriate amounts of the THF stock solution were then mixed with different volumes 
of MilliQ water under vigorous stirring to reach the final concentration of 10 µM with 
different water fraction (0–90 vol%). The PL spectra of these mixtures were then 
measured by LS-55 spectrometer.  
5.2.5 ROS Generation Measurement 
The ROS generation of DPBA-TPE aggregates or AIE dots under light 
irradiation was measured using dichlorofluorescin (DCFH) as the indicator. The PL 
spectra of the mixture of DPBA-TPE (10 µM) and DCFH (2 µM) were measured 
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before and after exposure to white light irradiation (250 mWcm-2) upon excitation at 
460 nm. The increase of fluorescence intensity at 530 nm is the indication of ROS 
generation in solution. The same experimental procedures were applied to AIE dots. 
5.2.6 Preparation of AIE Dots  
To synthesize AIE-FA dots, a THF solution (1 mL) containing DPBA-TPE 
(0.5 mg) and DSPE-PEG-FA (0.5 mg) and DSPE-PEG (0.5 mg) was poured into water 
(10 mL) under sonication using a microtip probe sonicator at 12 W output (XL2000, 
Misonix Incorporated, NY). The mixture was further placed in dark in fume hood for 
THF evaporation at 600 rpm overnight, and concentrated by centrifuge. To synthesize 
AIE-TPP dots, DSPE-PEG-NH2 (0.5mg) was used to replace DSPE-PEG-FA (0.5 mg) 
during the nanoparticle formation. The resultant AIE dots suspension with amino group 
at surface was reacted with excess triphenylphosphine (TPP). AIE-TPP dots were then 
dialysis against water with 6-8 kDa membrane to remove excess TPP. To synthesize 
FA-AIE-TPP dots, DSPE-PEG-FA (0.5 mg) and DSPE-PEG-NH2 (0.5 mg) were used 
as the matrix during dots formation. The AIE dots suspension was then reacted with 
TPP. FA-AIE-TPP dots were then dialysis against water using 6-8 kDa membrane to 
remove excess TPP.  
5.2.7 Confocal Imaging 
NIH-3T3 normal cells and MCF-7 cancer cells were cultured in 8-well chamber 
(LAB-TEK, Chambered Coverglass System) at 37 ºC. After 80% confluence, the cells 
were incubated for 4 h with these AIE dots (20 µg/mL based on DPBA-TPE mass 
concentration) suspended in cell culture medium, and then washed twice with PBS. To 
label mitochondria, the cells were further incubated with MitoTracker Green 
(Invitrogen, 200 nM) for 20 min. After washing, the cells were immediately imaged by 
confocal laser scanning microscope (CLSM). The red fluorescence from AIE-dots was 
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acquired above 650 nm upon excitation at 534 nm. The green fluorescence from 
MitoTracker Green was obtained between 505 to 560 nm upon excitation at 488 nm. 
5.2.8 Measurement of Mitochondrial Membrane Potential  
JC-1 dye (Invitrogen) was used to measure mitochondrial membrane potential 
(MMP) changes during PDT treatment. After 4h incubation of MCF-7 cells with these 
AIE dots (20 µg/mL based on DPBA-TPE mass concentration) suspended in cell 
culture medium. The cells were washed and exposed to light irradiation (100 mWcm-2) 
for 0, 5, and 10 min. MCF-7 cells were incubated with JC-1 dyes (2 µg/mL) for 20 min. 
After washing, the cells were immediately imaged by CLSM. Upon excitation at 488 
nm, the green signal was collected between 505 and 525 nm, and the red signal was 
collected above 590 nm. 
5.2.9 Flow Cytometry  
NIH-3T3 normal cells and MCF-7 cancer cells were cultured in 6-well plate at 
37 ºC. After 80% confluence, the cells were incubated with these AIE dots (20 µg/mL 
based on DPBA-TPE mass concentration) suspended in cell culture medium for 4 h. 
The cells were then harvested by trypsin, and resuspended in 1×PBS. Cyan-LX 
(DakoCytomation) was then used to access the fluorescence intensities of cells, where 
10,000 events were counted for the histogram analysis. 
5.2.10 Cell Migration Assay  
NIH-3T3 and MCF-7 cells were cultured into 6-well plates and grown for 24 h. 
Cell scratch spatula were applied to make a scratch in the cell monolayer. After rinsing 
the cells with PBS, the photographs of the scratches were taken using a microscope 
with a 10× objection (Nikon-Ti-U). The cells were then treated with AIE dots (20 
µg/mL based on DPBA-TPE mass concentration) for 4 h and followed by light 
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irradiation (100 mWcm-2, 10 min), the cells were further cultured for 72 h, after which 
the pictures were taken again. The migration ratio is determined by the number of cells 
migrated to wound area after PDT treatment to that of control cells without any 
treatment and light irradiation after 72 h. 
5.2.11 Cytotoxicity Studies  
The viability of NIH-3T3 and MCF-7 cells was evaluated using 
methylthiazolyldiphenyltetrazolium bromide (MTT) assays. Both cells were seeded in 
96-well plates (Costar, IL, USA) at an intensity of 4 × 104 cells/mL, respectively. After 
24 h incubation, AIE dots in DMEM suspensions at various concentrations were then 
added into each well. After 4 h incubation, the AIE dot suspensions were replaced by 
fresh cell culture medium. The selected wells were exposed to light irradiation (100 
mWcm-2, 10 min), and further cultured for 24 h. In the parallel experiment, both cell 
lines were treated with AIE dots for 24 h in dark. The cells were then incubated with 
MTT solution (0.5 mg/mL, 100 µL/well) for 3 h. After remove of MTT, filtered DMSO 
was then added (100 µL/well) and the plate was gently shaken for 10 min at room 
temperature to dissolve all the precipitates formed. Microplate reader (Genios Tecan) 
was then used to access the absorbance of MTT at 570 nm. Cell viability was 
determined by the ratio of the absorbance of the cells incubated with AIE dots to that 
of the cells incubated with culture medium only. The same experiment procedures were 
repeated by fixing the AIE dot concentration with varied light power or exposure time. 
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5.3 Results and Discussion 
5.3.1 Synthesis and Characterization of DPBA-TPE  
 
Scheme 5.1. Chemical structure of DPBA-TPE. 
To demonstrate the potential of AIE dots for cellular and mitochondria dual 
targeted image-guided PDT, a new AIEgen, DPBA-TPE (Scheme 5.1) with ROS 
production ability was and designed and synthesized by our collaborator in Hong Kong 
University of Science and Technology (HKUST). The structure of DPBA-TPE 
(Scheme 5.1) is comprised of the dimethoxybenzene and arylamines as the electron 
donor (D), cyano groups as the acceptor (A), as well as TPE groups as the iconic AIE 
unit. The introduction of D-A system to TPE groups is expected to generate a new 
AIEgen with increased electronic conjugation, and hence longer absorption and 
emission wavelengths. DPBA-TPE in THF showed an absorption spectrum peaked at 
480 nm. The AIE properties of DPBA-TPE were studied by measuring its 
photoluminescence (PL) spectrum changes in water/THF mixtures with different water 
fractions (fw) (Figure 5.1A). DPBA-TPE in THF shows weak orange-red fluorescence 
where the emission peaks at 619 nm. With the increase of fw (≤ 40%), the emission of 
DPBA-TPE is decreased and bathochromically shifted to 624 nm, due to solvent 
polarity increase and the transformation to the twisted intramolecular charge transfer 
(TICT) state. Upon further increasing fw, the emission of DPBA-TPE is invigorated 
from fw of ~50% and is further intensified. Collectively, these data indicate that DPBA-
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TPE possesses both AIE and TICT characteristics, while AIE plays a dominant role in 
determining their optical properties in aggregated states.  
 
Figure 5.1. A) PL spectra of DPBA-TPE (10 µM) in THF/water mixtures with different water 
fractions. B) PL spectra of DPBA-TPE (10 µM) and DCFH (2 µM) mixture in water with 
different white light irradiation time (250 mW cm-2). 
To study whether DPBA-TPE is able to generate ROS in aggregated state, 
dichlorofluorescin (DCFH) was used as the ROS indicator, which initially shows no 
fluorescence in aqueous solution but emits bright green fluorescence upon reaction with 
singlet oxygen. As shown in Figure 5.1B, the mixed aqueous solution of DPBA-TPE 
(10 µM) and DCFH (2 µM) showed quickly increased fluorescence centered at 530 nm 
upon exposure to white light irradiation (250 mW cm-2) within minutes, while DCFH 
itself under light irradiation remain weakly fluorescent, indicating that the DPBA-TPE 











































































aggregates are able to efficiently generate singlet oxygen species. Together with the 
bright red fluorescence in the aggregated state, it is highly predictable that the 
encapsulation of DPBA-TPE into organic dots will not compromise its imaging quality 
and PDT effect. 
5.3.2 Fabrication and Characterization of AIE dots 
 
Scheme 5.2. Schematic illustration of FA-AIE-TPP dots for specific targeting of FR-positive 
MCF-7 breast cancer cell mitochondria for image-guided PDT.   
To fabricate the dual targeting AIE dots, a modified nano-precipitation method 
as described in previous chapters was used (Scheme 5.2). Biocompatible block 
copolymers of lipid-PEG with different terminal groups, (1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[amino(polyethylene glycol)-2000]) (DPSE-PEG-NH2) and 
(1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate(polyethylene glycol)-
2000]) (DSPE-PEG-FA) were chosen as the encapsulation matrix. To bring the 
resultant AIE dots to mitochondria, cationic TPP, which is able to accumulate in 
mitochondria in response to high mitochondrial membrane potential (MMP),195, 196 was 
then reacted with AIE dot suspension to yield FA-AIE-TPP dots. After the reaction, 
dialysis of the FA-AIE-TPP dots suspension against water using 6 to 8 kDa cutoff 
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membrane was applied to remove excess TPP. Similar procedures were applied to 
fabricate folic acid mono-functionalized AIE dots (AIE-FA) and TPP mono-
functionalized AIE dots (AIE-TPP). The formed FA-AIE-TPP dots are expected to 
specifically internalize into folate receptor (FR) positive cancer cells, and subsequently 
accumulate in mitochondria for mitochondria imaging and enhanced PDT effects 
(Scheme 5.2).  
 
Figure 5.2. A) Absorption and PL spectra, and B) hydrodynamic diameters and surface zeta 
potentials of three AIE dots in water. TEM image of C) AIE-FA, D) AIE-TPP, and E) FA-
AIE-TPP dots. 
The absorption and PL spectra of FA-AIE-TPP dots in aqueous suspension are 
shown in Figure 5.2. The FA-AIE-TPP dot suspension showed two absorption peaks 
centered at 305 and 497 nm, respectively. The PL spectrum is centered at 624 nm with 
a fluorescence quantum yield of 14% using 4-(dicyanomethylene)-2-methyl-6-(p-
dimethylaminostyryl)-4H-pyran (DCM) in methanol as reference (43%). It should be 
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both AIE-FA and AIE-TPP dots showed similar absorption and PL spectra (Figure 
5.2A), which should be benefited from the excellent encapsulation ability of DSPE-
PEG. The hydrodynamic diameters of the three AIE dots were evaluated using laser 
light scattering (LLS). AIE-FA, AIE-TPP, and FA-AIE-TPP dots exhibit similar sizes 
of around ~30±1.2, ~35±1.7, ~34±1.5 nm with narrow size distribution, respectively 
(Figure 5.2B). The surface zeta potentials of the three dots are 9.8, 36.9, 28.9 mV for 
AIE-FA, AIE-TPP and FA-AIE-TPP dots, respectively. The increase of surface 
charge of AIE-TPP and FA-AIE-TPP dots should be due to the conjugation of TPP at 
dots surface, which also slightly increases the AIE dot sizes. High resolution 
transmission electron microscope (HR-TEM) was further applied to study the 
morphology and size distribution of these AIE dots. The FA-AIE-TPP dots are 
spherical in shape with a mean diameter of 31 nm, and AIE-FA and AIE-TPP dots 
exhibit similar spherical shapes with sizes around 28 nm and 32 nm (Figures 5.2C-E). 
In addition, no precipitation was observed after the AIE dots have been stored for 
several months, indicating the excellent colloidal stability. 
The PDT effect of the AIE dots is further studied by measuring the reactive 
oxygen species (ROS) generation efficiency under light irradiation using DCFH as an 
indicator. As shown in Figure 5.3, the FA-AIE-TPP dot suspension is able to generate 
ROS very quickly and efficiently under white light irradiation, which is evidenced by 
the rapid increase of DCFH fluorescence intensity at 530 nm. Moreover, increasing the 
exposure time, AIE dot concentration, or light power will also increase the ROS 
generation (Figure 5.3), indicating that ROS production of AIE dots is time-, 
concentration- and power-dependent. Such an efficient ROS generation capability 




Figure 5.3. ROS generation of FA-AIE-TPP dots in aqueous solution at A) varied dot 
concentrations with a fixed light power of 250 mWcm-2, and B) varied light powers with fixed 
dot concentration of 2 µg/mL upon irradiation for 300 s, using DCFH (2 µM ) as ROS indicator.  
 
5.3.3 Cellular and Mitochondria Dual Targeted Imaging 
The cellular targeting of the three AIE dots were investigated by flow cytometry 
and fluorescence imaging. FR-positive MCF-7 breast cancer cells were chosen as the 
target, with FR-negative NIH-3T3 fibroblast cells as the control. After incubating both 
cell lines for 4 h with the three AIE dots at 20 µg/mL based on DPBA-TPE mass 
concentration, flow cytometry was further applied to study the cellular uptake of AIE 
dots in MCF-7 and NIH-3T3 cells. All the three AIE dots treated NIH-3T3 cells only 
show very small increase in average fluorescence intensity, indicating the low cellular 
uptake of all the AIE dots into NIH-3T3 cells due to lack of cellular targeting ligands 
and the suppressed non-specific internalization by PEG (Figure 5.4A). On the other 
hand, FA-AIE-TPP and AIE-FA dots treated MCF-7 cells show similar average 
fluorescence intensities, which are much higher than those of blank or AIE-TPP dots 
treated MCF-7 cells (Figure 5.4B).  
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Figure 5.4. Flow cytometry histograms of A) NIH-3T3 cells and B) MCF-7 cells after 
incubation with AIE dots (20 µg/mL) for 4 h. 
The confocal images were then used to study the cellular targeting performance. 
Figure 5.5 shows the corresponding fluorescence images of these AIE dots treated 
either MCF-7 or NIH-3T3 cells. For FA-AIE-TPP or AIE-FA dots incubated cells, 
much stronger red fluorescence can be observed for MCF-7 cells than NIH-3T3 cells, 
revealing the targeting capability of folate decorated AIE dots towards FR-positive cells. 
While, AIE-TPP dots show very weak fluorescence inside both cell lines. The confocal 
images are in consistent with flow cytometry results, indicating that folic acid 
decoration promotes the cellular uptake of AIE dots to FR-positive cells. As TPP is able 
to drive FA-AIE-TPP dots to mitochondria, the similar cellular uptake between AIE-
FA dots and FA-AIE-TPP dots should provide insights into the important roles of the 












































Figure 5.5. CLSM images of A) MCF-7 cancer cells and B) NIH-3T3 normal cells after 
incubation with AIE dots (20 µg/mL) and MitoTracker Green (200 nM). AIE dots: Ex: 543 nm, 
Em: > 650 nm; MitoTracker Green: Ex = 488, Em = 505 – 525 nm. The scale bar size is 10 µm 
for all images. 
To test whether these AIE dots are able to accumulate at mitochondrial sites, 
commercially available mitochondrial tracker MitoTracker Green (Invitrogen) was 
used as the co-stain. The red fluorescence from FA-AIE-TPP dots clearly shows a 
characteristic mitochondrial network inside MCF-7 cells (Figure 5.5A), which is in 
consistent with green fluorescence emitted from MitoTracker Green. Without TPP 
decoration, AIE-FA dots are randomly distributed inside MCF-7 cancer cells, 
indicating that the existence of TPP drives the accumulation of AIE dots to 
mitochondria. Due to the poor cellular uptake of AIE-TPP dots as previously described, 
poor visualization of mitochondrial pattern in MCF-7 cells is observed. On the other 
hand, besides very weak red fluorescence, its poor overlap with the green fluorescence 
from MitoTracker green is observed for NIH-3T3 cells, indicating the poor cellular 
uptake and mitochondria localization of all three AIE dots in FR-negative cells (Figure 
5.5B). The Pearson’s correlation coefficients are also used to quantify the co-
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MCF-7 cells, and 0.29, 0.40, 0.31 for NIH-3T3 cells, for FA-AIE-TPP, AIE-FA, and 
AIE-TPP dots, respectively. The higher Pearson’s coefficient of AIE-TPP dots in 
MCF-7 than NIH-3T3 cells should be ascribed to the higher MMP of cancer cells over 
normal cells, which promoted mitochondria accumulation of AIE-TPP dots in MCF-7 
cells. The highest Pearson’s coefficient for FA-AIE-TPP dots towards MCF-7 cell 
mitochondria clearly demonstrates that modifying the mitochondria targeted 
nanocarriers with secondary cellular targeting ligands is able to enhance their cellular 
uptake towards targeted cells with subsequent mitochondria accumulation.  
 
5.3.4 Photodynamic Therapy of AIE Dots 
 
Figure 5.6. Viabilities of MCF-7 cancer cells and NIH-3T3 normal cells after incubation with 
A) AIE-TPP, B) AIE-FA, C) FA-AIE-TPP dots at varied concentrations, followed by white 
light irradiation (250 mWcm-2). D) and E) Annexin V labeled MCF-7 cells after incubation 
with FA-AIE-TPP dots (20 µg/mL) without (D) or with (E) light irradiations (250 mWcm-2). 
D) and E) share the same scale bar. 
The PDT effects of the three AIE dots on viabilities of NIH-3T3 and MCF-7 
cells were then investigated by MTT assays. Upon incubation with the three AIE dots 
in dark for 24 h, both NIH-3T3 and MCF-7 cells exhibit high cell viabilities of over 90% 
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even at a high DPBA-TPE concentration of 80 µg/mL, indicating the low cytotoxicity 
of AIE dots without light irradiation. In the parallel experiments, incubating both cell 
lines with AIE dots for 4 h and followed by light irradiation (100 mWcm-2) for 10 min 
leads to large differences in cell viabilities (Figures 5.6 A-C). All three AIE dots exhibit 
very low photo-toxicity towards NIH-3T3 cells, which should be due to the poor 
cellular uptake. As for MCF-7 cells, FA-AIE-TPP dots show the most efficient killing 
efficiency under light irradiation with a cell viability of less than 10% at the DPBA-
TPE concentration of 80 µg/mL. While under the same condition, AIE-TPP and AIE-
FA dots treated MCF-7 cells show cell viabilities of ~60% and ~32%, respectively. The 
half maximal inhibitory concentration (IC50) was further applied to quantify the 
anticancer efficiency of the three dots under light irradiation. The IC50 values are >80, 
~32, and ~10 µg/mL for AIE-TPP, AIE-FA, and FA-AIE-TPP dots, respectively. As 
almost the same amount of AIE-FA and FA-AIE-TPP dots are internalized into MCF-
7 cells as revealed by CLSM and flow cytometry (Figures 5.4 and 5.5), the lower IC50 
of FA-AIE-TPP dots clearly indicates that localizing PS loaded nanocarriers in 
mitochondria helps enhance anticancer effects of PDT. The comparison between AIE-
TPP and FA-AIE-TPP dots also reveals that the increased cellular uptake of the latter 
helps increase the amount of NPs accumulated at mitochondria to yield enhanced PDT. 
Moreover, the killing efficiency of FA-AIE-TPP dots towards MCF-7 cells also 
increases with the exposure time and light power.  
PDT triggered cell death normally destroys the mitochondria membrane and 
triggers the release of cytochrome, leading to apoptosis process. We used fluorescein 
isothiocyanate (FITC)-tagged Annexin V to differentiate apoptotic cells from viable 
ones. As shown in Figures 5.6 D and E, incubating MCF-7 cells with FA-AIE-TPP 
dots in dark, almost no green fluorescence from Annexin V is observed. While upon 
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light irradiation, bright green fluorescence originated from Annexin V can be observed 
from cell membrane, indicating that MCF-7 cells undergo apoptosis process in the 
presence of FA-AIE-TPP dots and light irradiation.  
5.3.5 Mitochondria Membrane Potential Study  
 
Figure 5.7. A-C) MMP changes of FA-AIE-TPP dots (20 µg/mL) treated MCF-7 cancer cells 
measured by JC-1 (2 µg/mL) after light irradiation (100 mW cm-2) for A) 0, B) 5, and C) 10 
min. D) MMP changes of MCF-7 without FA-AIE-TPP dots treatment under light irradiation. 
All the images share the same scale bar. 
It has been reported that PDT treatment on mitochondria can cause 
mitochondria damage, leading to cell apoptosis and death. One of the characteristics of 
mitochondria damage or dysfunction is the loss of mitochondria membrane potential 








(MMP), which will trigger the release of cytochrome at early stage of apoptosis.164-166 
We used a membrane-permeable JC-1 dye to monitor MMP changes during PDT 
treatment. JC-1 dye undergoes reversible fluorescence changes between its aggregate 
and monomer states. At high MMP level, JC-1 forms red emissive fluorescent 
aggregates on normal mitochondria, while it is shifted to green emissive monomer on 
depolarized mitochondria with low MMP. Figure 5.7 shows the representative confocal 
images of JC-1 assays, and the green/red (G/R) ratio helps quantify the MMP loss of 
MCF-7 cells during PDT. The accumulation of FA-AIE-TPP dots in mitochondria in 
dark does not de-polarize the mitochondria membrane as evidenced by the dim green 
fluorescence and bright red fluorescence from JC-1 dye. Upon exposure to white light, 
the JC-1 staining changes, where green fluorescence increases at the expense of red 
fluorescence (G/R ratio changes from 0.46 to 3.59 and 4.37), indicating the loss of 
MMPs and damage of mitochondria upon light irradiation. In addition, irradiation of 
blank MCF-7 cancer cells does not cause obvious MMP changes (Figure 5.7D), further 
indicating that mitochondria damage is due to the ROS generated by AIE dots under 
light illumination. It should be noted that the red fluorescence emitted from FA-AIE-
TPP dots is still observable during PDT treatment, which provides the opportunity to 
visualize the morphology changes of mitochondria from characteristic tubular-like 
structure to dot-like structures after light irradiation. 
5.3.6 Cell Migration Study 
As the powerhouse of cells, mitochondrion provides the major energy for cancer 
cell activities, including proliferation, migration and metastasis. It is postulated that the 
dysfunction of mitochondria highly affects the ATP production and hence the migration 
of cancer cells. A cell-scratch spatula method is used to study the effects of AIE dots 
on cell migration before and after light irradiation. A scratch was applied to the cell 
 115 
 
monolayer prior to 4h incubation with these three AIE dots (20 µg/mL based on DPBA-
TPE mass concentration) and light irradiation (100 mWcm-2, 10 min). The migration 
ratio is determined by the number of cells migrated to the wound area after PDT 
treatment to that of control cells without AIE dots treatment and light irradiation after 
72 h post-culture (Figure 5.8). The AIE dots and light irradiation did not affect the 
migration ability of NIH-3T3 cells, as they migrated into the wound area with a very 
high migration ratio of ~100%. On the other hand, AIE dots in dark do not affect the 
migration ability of MCF-7 cells, but further light irradiation is able to inhibit the wound 
closure of AIE dots treated MCF-7 cells, with migration ratios of 74.2%, 54.1%, and 
6.8% for AIE-TPP, AIE-FA and FA-AIE-TPP dots, respectively (Figures 5.8B). As 
cancer cells are highly metastatic, the inhibition of migration should also contribute to 
the anticancer therapy.  
 
 
Figure 5.8. A) White field image of FA-AIE-TPP dots treated NIH-3T3 and MCF-7 cells 
before (up) and after 72 h culture (bottom). Both cells were incubated with FA-AIE-TPP dots 
(20 μg/mL based on DPBA-TPE mass concentration) for 4 h, followed by light exposure (100 
mW/cm2) for 10 min. B) The effects of AIE dots treatment on migration of MCF-7 cells with 










































In summary, we fabricated dual-targeted AIE dots with efficient ROS 
generation for FR-positive cancer cell and mitochondrial dual targeted image-guided 
PDT. The new AIE dots showed bright red fluorescence and efficient ROS generation 
under light irradiation. To specially target the mitochondria of a selective type of cancer 
cells, the AIE dot surfaces were decorated with folate acid and TPP. Folate acid 
promotes the cellular uptake to FR-positive cancer cells, and TPP drives AIE dots to 
accumulate in mitochondria. The generation of ROS at mitochondria is able to quickly 
depolarize and destroy the mitochondrial membrane, and largely affects cancer cell 
migration ability. Cell viability studies revealed that dual functionalized FA-AIE-TPP 
dots showed more efficient anticancer PDT effects than single ligand functionalized 
AIE-TPP or AIE-FA dots. Different from traditional approaches which require tedious 
processes to modify PSs for targeted PDT, this AIE dots strategy provides a new 
platform for cellular- and organelle-targeted image-guided PDT. Moreover, when the 
developed strategy is further applied to other imaging or therapeutic reagents, it opens 
















6.1  Conclusions 
Fluorogens with aggregation-induced emission (AIEgens) have recently 
received remarkably increasing attentions in biological applications due to their largely 
enhanced fluorescence in aggregated state, tuneable optical properties, and good 
photostability. As compared to conventional fluorescence probes including organic 
dyes, QDs, fluorescence proteins, the exploration of AIEgens and AIEgens based 
nanoparticles (NPs) in bioimaging and theranostic applications is promising with great 
potentials, but still in its very early stage. The main objective of this thesis is to develop 
AIEgens based organic dots (AIE dots) for targeted cancer cell or subcellular organelle 
detection, tracing, and therapy with high selectivity, good sensitivity and excellent 
therapeutic effects. The in vivo blood vascular integrity and leakage was also explored. 
These applications are of high importance in the early stage of cancer diagnosis, 
inflammation and infection detection, and the treatment of tumours. The detailed and 
significant findings obtained during the thesis study are summarized as following. 
Firstly, we developed a facile and general encapsulation approach using DSPE-
PEG as the matrix to fabricate AIE dots with ultrahigh brightness, good colloidal 
stability, and excellent photostability. Due to the existence of the PEG chains as the 
protective shells, the nonspecific interactions are largely suppressed, which increases 
the imaging sensitivity and contrast. Benefiting the excellent encapsulation ability of 
chosen DSPE-PEG, the obtained AIE dots showed high fluorescence quantum yield 
over 60%. Using the method we designed, the surface functional groups of the resultant 
AIE dots are easily amendable by simply changing the terminal groups of DSPE-PEG. 
In this chapter, the AIE dots are further conjugated with cell penetration peptide to 
enhance their cellular uptake towards targeted cells. The AIE dots showed excellent 
labelling performance towards all tested cells including primary cells and stem cells, 
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which outperforms the selected benchmark of non-viral green fluorescence protein 
(GFP) transfection method. These AIE dots showed excellent cellular retention where 
no leakage is observed during cell proliferation, and they can trace the activities of cells 
up to 10 days. 
We further synthesized a hybrid AIE dots with surface gadolinium chelation 
and bright red fluorescence under two-photon excitation for in vivo imaging and 
detection of blood vascular integrity and leakage under inflammation. The PEG shells 
prevent the nonspecific interaction of AIE dots with biomolecules in blood vascular, 
which provides the clear, distinguishable and continuous red emissive flow inside blood 
vascular. Different from small organic dyes whose fluorescence are largely susceptible 
to surrounding environment, our AIE dots showed stable brightness in blood vessels. 
Under inflammation or infection, the vascular permeability will increase, and our AIE 
dots will leak outside from the blood vascular, serving as an in vivo fluorescence marker 
for blood vascular integrity and leakage. Moreover, the gadolinium contents chelated 
onto the AIE dots can also provide the quantitatively analysis of the leakage, providing 
a guidance of the inflammation severity. In this chapter we provide a new strategy to 
introduce magnetic modality to fluorescence NPs without affecting the optical 
properties. With the combination of two modalities, we provide more accurate and 
sensitive detection of inflammation. 
Thirdly, we discovered that some AIEgens can act as photosensitizers (PSs). 
Taking TPETPADCM as an example, TPETPADCM is able to efficient generate 
reactive oxygen species (ROS) even in aggregated states. Utilizing the similar methods 
established in previous chapters, TPETPADCM was encapsulated into DSPE-PEG NPs, 
which is further conjugated with cRGD that can target towards αvβ3 integrin 
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overexpressed cancer cells. We demonstrated that the resultant TPETPADCM-cRGD 
dots are able to emit bright red fluorescence and efficiently generate ROS under proper 
light irradiation. They were further applied to visualize the targeted cancer cells and 
selectively kill them through the photodynamic effects. For the first time, we 
demonstrated AIEgens themselves can efficient generate ROS even in aggregated states. 
This PDT platform based on AIEgens is simple to design and synthesis, which offers 
new opportunities for image-guided PDT. 
Due to short lifetime and action of radius of ROS, the performance of PDT is 
greatly limited to its subcellular distribution, as mitochondrion is the main targeted of 
ROS, the address of PSs to mitochondria will largely enhanced the PDT efficiency. As 
such, in addition to the image-guided PDT towards targeted cells as described in 
previous chapter, subcellular mitochondria targeting and labelling in living targeted 
cells was also carried out using cellular and mitochondria dual targeted AIE dots for 
enhanced photodynamic performance.  A new AIEgen, DPBA-TPE with bright red 
emission and efficient ROS production was synthesized and encapsulated to DSPE-
PEG matrix to form the AIE dots. The surfaces of AIE dots were further functionalized 
with folic acid and TPP to address the AIE dots to the mitochondria of folate receptor 
positive cancer cells. The generation of ROS at mitochondria is able to quickly 
depolarize and destroy the mitochondrial membrane, which showed more efficient 
anticancer PDT effects than sole cellular targeted or mitochondria targeted AIE dots. 
Moreover, this facile strategy is of high importance in subcellular targeting imaging 
and therapy, as it does not require tedious processes to modify drugs or dyes. 
In this thesis, we have successfully demonstrated the design of AIE dots for 
different biological applications varying from in vitro to in vivo, for cells to organelles, 
from diagnosis to therapy. Instead of fight against the ACQ effects associated with 
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aggregation, the developments of AIEgens are able to take the advantages of nature and 
inevitable phenomenon of aggregation, making it possible to fabricate NPs with high 
brightness for detection and imaging in biological environment. Instead of chemical 
modification of AIEgens to synthesize light-up probes or AIE nanoparticles, this thesis 
clearly demonstrated a facile and general approach to fabricate AIE dots with ultra-high 
brightness and other optical properties to fulfil different requirements in these 
biological applications. The ultrahigh brightness, tuneable emission colour, good 
photostability and colloidal stability make them promising contrast reagents over 
fluorescent proteins, organic dyes and quantum dots. In addition, the efficient ROS 
production in aggregate state further expanded their applications in photodynamic 
therapy. In the view of material science and applications, the AIE dots with desired 
optical or therapeutic properties can be fine-tuned by choosing the suitable AIEgens, 
matrices or strategies. Due to the ACQ effects of conventional fluorogens, the 
fabrication of nanoparticles with bright fluorescence or efficient ROS production is 
greatly limited, this thesis thus provides a new solution to fabricate fluorescent AIE 
nanoparticles with high brightness or efficient ROS generation for imaging, theranostic 
and other biological applications. 
6.2  Recommendations 
We have successfully demonstrated the synthesis of AIE dots in different 
biological applications, which possess promising potentials that are worth of further 
exploration. With the rapid development of AIE field, and in the parallel to the study 
of this thesis, many new approaches and applications of AIE dots have been 
demonstrated. Based on these results obtained in this thesis and others demonstrations, 
we propose some recommendations for further optimization and investigation of AIE 
dots in more broadened biological applications. 
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AIE dots with ultrahigh brightness have been successfully synthesized in this 
thesis. The current method for AIE dots fabrications demonstrated in this thesis is based 
on DSPE-PEG as the matrix. This is due to the excellent encapsulation performance of 
DSPE-PEG, and the high colloidal stability of the resultant AIE dots. The method 
demonstrated in this thesis is capable to deliver AIE dots with size around ~30 nm. 
Although they have shown promising performance in biological applications, the AIE 
dots with different sizes are still highly desirable in biological applications. For example, 
the nucleus imaging by AIE dots in living cells is still limited, due to the relative larger 
particle size than the nucleus membrane pore. As a consequence, it would hold great 
potentials to design and develop AIE dots with different particle sizes. It should be 
noted that, although the estimation of AIE nanoparticles based on gravimetric 
measurement via diving the sample by unit weight of nanoparticles is simple and 
straightforward, its error ranges are largely dependent on many factors. For example, 
an average diameter is used for concentration estimation due to the intrinsic 
polydispersity of polymeric nanoparticles. For accurate estimation, the size distribution 
of AIE particles should be as small as possible, which required the optimization of 
current AIE dot fabrication to reduce the polydispersity. On the other hand, the particle 
density estimation also need to improve, as small inorganic particles in nm range can 
be well dispersed in water even if their density is much larger than water. And the use 
of the bulk matrix and AIEgens density also introduce experimental error. New and 
advanced analytical technique and theoretical calculation approach should be 
developed for reduction the error of nanoparticle concentration determination. 
Another important aspect need further investigation is the packing and 
distribution of AIEgens inside these organic dots. As implied by its name, AIEgens 
showed intensified emission that is aroused by the formation of aggregates. Benefiting 
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from this feature, we are able to fabricate the AIE dots with high emission for biological 
applications. However, currently rare reports how these AIEgens are aggregated and 
packed inside these NPs, and how they will affect the brightness of the resultant dots. 
It is also observed that the brightness of AIE dots is not always as the same as these 
AIEgen aggregates in water at the same concentration. It indicates that we still have not 
made the full use of the aggregation of these AIEgens, which still awaits for the further 
exploration. Moreover, the mechanism of these AIEgens with efficient ROS production 
in aggregate state also need further investigation. 
Multifunctional AIE dots integrated with different imaging modalities also need 
further exploring. Currently, the applications of AIE dots is still limited to in vitro or in 
vivo subcutaneous level due to the limited penetration depth and the interference from 
biological tissues. This can be overcome by integrated the fluorescence imaging with 
other modalities as such magnetic resonance imaging (MRI) to provide multiple signals. 
MRI can provide images with high penetration depth but low resolution. This 
combination of fluorescence AIE dots with MRI reagents could take the advantage of 
both imaging modalities. We have conducted some works by chelating gadolinium onto 
AIE dots surface for dual modality detection of blood vascular leakage (Chapter 3), but 
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